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ABSTRACT 
Strawberries and Gut Health in Postmenopausal Women 
Morgan T. MacNeill 
The gut microbiota has been implicated in both health and disease. As such, diet is a 
significant determinant of gut health, whereby diet induced dysbiosis is associated with 
cardiometabolic risk. Interestingly, a higher proportion of Firmicutes and a lower 
proportion of Bacteroidetes are implicated in obesity. Strawberry polyphenols have 
been shown to reduce cardiovascular disease risk in addition to exhibiting prebiotic 
activity by increasing probiotic bacteria in the gut. Polyphenols have also been shown to 
reduce the ratio of Firmicutes to Bacteroidetes. Therefore, dietary modifications such as 
strawberry consumption may help improve health outcomes through the gut. The 
objective of this study was to analyze whether 13 g freeze dried strawberry powder (~1 
cup/d fresh) consumption reduces the Firmicutes:Bacteroidetes ratio and increases 
microbial diversity and beneficial bacteria like Lactobacillus and Bifidobacterium. This 
study was a 5-week free-living diet intervention trial conducted at California Polytechnic 
State University, San Luis Obispo and The Eye Medical Center of Fresno. Participants 
(n=10) had a mean age of 60.5 ± 9.13 years and had a mean body weight of 74.71 ± 
10.61 kg. The participants completed a 3-week washout before a 2-week diet 
intervention. Participants maintained their normal diet throughout the study while 
eliminating foods high in polyphenols and probiotics. Upon completion of the study, no 
significant differences were found for body weight (p=0.22) or BMI (p=0.26). Likewise, 
no significant differences were found for macronutrient, vitamin, or mineral intake 
except for sugar (p=0.03), vitamin B12 (p=0.03), and fruit (p=0.0014). Bacteria 
abundance and diversity were not found to be statistically significant following 
intervention. Since strawberry supplementation was not associated with a significant 
change in the relative abundance of bacteria with the dose and duration administered, a 
randomized controlled trial would better determine the effect of strawberry 
consumption on gut health.  
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1. INTRODUCTION 
Recent research has identified an association between the gut microbiota and overall 
health. Known factors such as genetics and lifestyle choices are shown to influence the 
composition of the gut microbiota. Specifically, research has shown a significant 
relationship between diet and the gut microbiota.1 Diet affects a variety of variables 
related to gut health. For instance, diet-induced dysbiosis (imbalance of healthy and 
harmful gut bacteria) has been linked to atherosclerosis, obesity, and type 2 diabetes.2 
Additionally, research has demonstrated the association between the ratio of the phyla 
Firmicutes and Bacteroidetes and specific health outcomes. For example, an increased 
Firmicutes:Bacteroidetes (F:B) ratio potentially contributes to adiposity through greater 
energy harvest and activation of lipopolysaccharide (LPS) accompanied by changes in 
the intestinal barrier integrity.3 
Recent literature has also identified a relationship between sex hormones, the gut 
microbiota, and their link to various disease states. Specifically, postmenopausal women 
see a decline in estrogen as they begin menopause4 which is accompanied by an 
increased risk for CVD.5 Research has found that CVD risk may be related to the gut 
microbiota’s ability to process estrogen.6 Lifestyle choices like diet may exacerbate this 
process by contributing to a state of dysbiosis, and therefore, resulting in decreased 
ability to metabolize estrogen.6 As it stands, postmenopausal women have a high 
Firmicutes:Bacteroidetes ratio compared to men, and reduced baseline short chain fatty 
acid (SCFA) metabolism, both of which may also contribute to the pathogenesis of CVD.7  
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As such, diet, especially fruit intake, may be an effective approach to improve health 
outcomes through the gut. Namely, polyphenols found in strawberries have been 
reported to stimulate growth of commensal and probiotic bacteria while selectively 
inhibiting pathogen growth.8  
Previous diet intervention trials have investigated the consumption of various high 
polyphenol fruit, berry polyphenols, and berries on the human gut microbiota profile9-19 
whereas studies that assess the impact of strawberry consumption on the gut have yet 
to be investigated. The effect of strawberry consumption on the composition and 
diversity of the gut microbiota in overweight postmenopausal women is currently 
unknown.  
Given the documented negative impact of lifestyle choices, including diet, on gut 
health,1 and the potential for strawberry consumption to mitigate these effects, daily 
strawberry intake could be an alternative to expensive treatment methods that can 
generate unwanted side-effects. Thus, the objective of this study is to assess and 
determine the effect of strawberry consumption on the diversity and composition of the 
gut microbiota. It is hypothesized that daily consumption of 13 g (~1 cup fresh 
strawberries) freeze-dried strawberry powder will reduce the ratio of Firmicutes to 
Bacteroidetes while also increasing the microbial diversity and the abundance of several 
probiotic bacteria including Bifidobacterium and Lactobacillus.  
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2. LITERATURE REVIEW 
2.1 Gut Microbiota in Healthy Individuals 
The bacteria that inhabit the gut have the potential to influence overall human health 
and well-being. Gut microbes produce large numbers of bioactive compounds, including 
vitamins and short-chain fatty acids (SCFAs), that promote cellular mechanisms which 
maintain tissue integrity.1 However, while a large majority of the bacteria are 
innocuous, they may also play a role in chronic diseases.20 Recent findings have 
consistently observed that low bacterial diversity is associated with different diseases 
and health conditions including obesity and intestinal inflammation.21 As such, the exact 
role of the gut microbiota in the onset of disease is still being explored. That is, does 
disease precede changes to the microbiota composition or do changes in the gut 
composition lead to disease. Nonetheless, microbial diversity has been linked with the 
metabolic functions of the gut bacteria, and thus has the potential to influence human 
health.21  
2.1.1 Composition of the human gut microbiota  
The human gastrointestinal tract represents a large microbial ecosystem, housing 
several trillion microbial cells, specifically bacteria.22 To date, there have been over 50 
bacterial phyla identified,23 with Bacteroidetes and Firmicutes representing 
approximately 90% of the gut microbiota24; Proteobacteria, Actinobacteria, 
Verrucomicrobia, and Fusobacteria exist in smaller proportions (Figure 1).24 
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Figure 1. Predominant taxonomic gut microbiota composition, Rinninella, 2019.24 
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 2.1.1.1     Predominant gut bacteria and their functions 
 
2.1.1.1.1 Bacteroidetes 
 
The Bacteroidetes phylum make up ~23% of the gut composition25 and includes genera 
known for their role in human health. Bacteroides (approximately 75% of the 
Bacteroidetes phylum26) and Prevotella are two genera within the Bacteriodetes phylum 
which specialize in the metabolic conversion of protein and complex carbohydrates (i.e. 
plant polysaccharides like cellulose, starch, pectins, and xylans) to their respective 
metabolites. In addition, the Bacteroidetes phylum are major producers of the SCFA 
propionate27 while some Bacteroides spp. deconjugate bile acids.28   
2.1.1.1.2 Firmicutes 
 
The Firmicutes phylum constitutes ~50%-80% of the gut microbiota.28 Notable genera 
include Clostridium, Lactobacillus, Bacillus, Enterococcus, and Ruminicoccus; Clostridium 
represents 95% of the Firmicutes phylum.24 Most butyrate productions occurs in the 
Firmicutes phylum29 with several microbial communities capable of fermenting 
carbohydrates to lactate.28 For instance, Streptococcus spp. ferment simple sugars into 
lactate, and the lactate is converted into propionate by Veillonella spp.28 Likewise, the 
Lactobacillus spp. produce lactic acid from carbohydrate fermentation and 
Ruminococcus spp. degrade resistant starch to produce acetate.28  
2.1.1.1.3 Actinobacteria 
 
Though the Bacteroidetes and Firmicutes phyla dominate the gut microbiota, there are 
some phyla present in smaller quantities that play a significant role in human health. 
The Actinobacteria phylum composes ~3% of the gut microbiota25 and is dominated by 
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the Bifidobacterium genus.29 Bifidobacterium spp. are predominant in the infant gut 
(90% of total microbiota), and their abundance declines to <5% in adults.29 This genus 
contributes to gut health by producing lactate and acetate through carbohydrate 
fermentation.29 Bifidobacterium ferment non-digestible carbohydrates including 
resistant starch, pectin, inulin, cellulose as well as carbohydrates like mucin and human 
milk oligosaccharides produced by the host.29 In addition, Bifidobacterium can produce 
vitamin B12 and defensive bacteriocins.29 Other phyla represented in Figure 1 (i.e. 
Proteobacteria; Fusobacteria; Verucomicrobia) will not be detailed as they are not phyla 
and/or include genera that directly relate to the study objectives (objectives are 
discussed in section 3.1). 
2.1.2  Functions of the human gut microbiota 
Through ongoing research, it is recognized that gut microbial communities function like 
an organ that benefit both the host and the bacteria.30 Collectively, the functions of the 
gut microbiota can be broken down into three categories: metabolism, biosynthesis, 
and effect on the intestinal environment. As such, the gut microbiota are critical in the 
daily functioning of the human body by degrading non-digestible food compounds, 
synthesizing essential vitamins and SCFAs and assisting in producing metabolic end-
products.29 The microbiota also stimulate the host immune system to produce defensive 
agents against harmful bacteria, and therefore maintain a favorable environment for 
native commensal bacteria.31  
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2.1.2.1    Colonic Metabolism 
 
The gut microbiota play a significant role in the digestion and colonic metabolism of 
food compounds, including dietary nutrients and phytochemicals. For example, 
Bacteroides thetaiotamicron produces a collection of enzymes in a multi-step 
degradation of carbohydrates.1 In addition, bacterial phytases can degrade phytic acid in 
grains which release minerals including calcium, magnesium, and phosphate.1 
Additionally, degradation of the polysaccharide and protein rich mucus layer allow 
bacteria to meet their own energy needs while assisting in the turnover of the mucus 
layer.1 Establishing a healthy mucus layer has been found to maintain endothelial 
integrity, therefore, preventing potentially harmful gut conditions such as 
endotoxemia.1 
2.1.2.2    Bile acid metabolism 
 
Bile acids are needed to facilitate the absorption of fat, cholesterol, and fat-soluble 
vitamins from the intestine. The bile acids that do not recirculate to the liver are de-
conjugated by gut bacterial bile salt hydrolases (BSH), generating secondary bile acids.32 
De-conjugation reactions including dihydroxylation, dehydrogenation, and 
epimerization are performed by, but not limited to, the genera Bacteroides, Clostridium, 
and Eubacterium.33 Recent literature has determined an association between bile salt 
hydrolase activity and control of obesity and hypercholesterolemia. Joyce et al. found 
that by elevating BSH, it reduced weight gain, serum cholesterol, and liver triglycerides 
by directing expression of signaling pathways known for their role in lipid metabolism, 
circadian rhythm, and epithelial cell function.34   
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2.1.2.3    Biosynthesis 
 
2.1.2.3.1 Vitamin production 
 
A well-documented function of the gut microbiota is its role in the biosynthesis of 
vitamins. Gut bacteria like Actinobacteria and Bacteroidetes can generate vitamin K and 
B group vitamins including thiamin, biotin, cobalamin, niacin, pyridoxine, folate and 
vitamin B1235. Intestinal production of several vitamins individually contributes to a 
quarter or more of the suggested daily reference intake. For instance, production of 
folate, niacin, pyridoxine, and cobalamin reach 37, 27, 86, and 31 percent of the 
suggested dietary intake respectively.35 These vitamins participate in numerous 
metabolic reactions throughout the body, with significant roles in blood clotting, 
hematopoiesis, and tissue repair which maintain healthy nervous and cardiovascular 
systems.36  
2.1.2.3.2 Short Chain Fatty Acid production 
 
One of the most physiologically important products of the gut microbiota are the SFCAs 
produced by microbial fermentation of non-digestible dietary fiber.1 SCFAs provide 
energy for colorectal tissues and bacteria and promote cellular mechanisms that 
encourage tissue integrity.1 The SCFAs consist of acetate, butyrate, and propionate 
which collectively contribute to host health through various processes.37  
All three SCFAs can decrease pH in the colon which deters pathogen growth. Specifically, 
acetate increases blood flow and oxygen uptake in the colon, acts as a co-substrate to 
produce butyrate, and once absorbed, is an energy source for muscle and brain tissue.29 
Propionate prevents proliferation of and induces apoptosis of colorectal cancer cells, 
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interacts with the host immune system, promotes satiety, lowers blood cholesterol 
levels and improves insulin sensitivity.29 In a human study, inulin-propionate ester 
significantly increased postprandial plasma PYY and GLP-1, and over the course of 24 
days, propionate supplementation significantly reduced weight gain, intra-abdominal 
adipose tissue distribution, and intrahepatocellular lipid content. Propionate also 
prevented the decline in insulin sensitivity that was observed in the inulin-control 
group.38 Epidemiological evidence also suggests that propionate can travel through the 
circulatory system to impact immune function and inflammation in peripheral tissues 
such as the lung.1 Lastly, butyrate stimulates the absorption of water and sodium in the 
colon, reduces oxidative stress, prevents colon cancer and colitis, and improves gut 
barrier function by stimulating mucin formation, antimicrobial peptides, and tight-
junction proteins.29 These effects may reduce the likelihood of endotoxemia should any 
pro-inflammatory substances leak across the gut barrier.39 Butyrate also acts to increase 
host insulin sensitivity by stimulating the release of gastric inhibitory polypeptide from 
enteroendocrine K-cells.39 Metabolically, both butyrate and propionate can regulate 
energy intake, expenditure, and storage by stimulating the release of the satiety 
hormones glucagon-like peptide 1 (GLP-1) and peptide YY from enteroendocrine L-cells, 
therefore encouraging satiation.38,39  
2.1.2.4    Effect on the intestinal environment 
 
Another vital role of the gut microbiota is protecting against pathogen colonization and 
maintaining a healthy gut environment.31 The microbiota achieve this homeostasis 
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through competitive metabolic interaction, recruiting host immune responses, and 
encouraging vascularization.  
The gram negative and gram positive native commensal bacteria deter pathogen growth 
by producing bacteriocins and proteinaceous toxins that inhibit members of the same 
bacterial species. For instance, E. coli can produce bacteriocins when it needs to fend off 
the related pathogen enterohaemorrhagic E. coli.31 Commensal bacteria and SCFAs can 
also alter the pH of the gut environment to a level that prohibits pathogen colonization.1 
This allows the commensal bacteria to occupy intestinal niches as colonization sites that 
could otherwise be filled by pathogenic bacteria.31  
Additionally, the commensal bacteria fend off pathogens and encourage epithelial 
integrity by communicating with the host immune system. Since the lining of the gut is 
the largest surface area in contact with exogenous antigens, the gut microbiota play a 
central role in mucosal immunity and potentially preventing bacterial translocation.23 
Research shows that the commensal bacteria promote epithelial barrier function by 
synthesizing antimicrobial peptides resulting in fewer scenarios of pathogen 
translocation.31 Over time, the presence of commensal bacteria may result in decreased 
incidence of pathogen associated disease.  
Research has also investigated the role of the intestinal bacteria in vascularization. 
Stappenbeck et al. compared germ-free mice and B. thetaiotaomicron-colonized 
transgenic mice with Paneth cells and found that the bacteria shaped the development 
of the intestinal villus microvasculature through Paneth cell dependent interaction.40 
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This study emphasizes how the gut microbiota may better promote absorption of 
nutrients through increased vascularization.   
2.1.3 Gut associated disease states 
Through their many functions, gut bacteria have the capacity to help or harm the human 
body. Small disturbances to their environment, and therefore the gut ecology, can result 
in systemic complications for the human host. As such, dysbiosis and low diversity have 
been associated with various disease states.2  
The diversity of the gut microbiota has been associated with human health.41 A healthy 
gut microbiota is characterized by high diversity with the ability to resist change under 
stress, while lower species diversity and fewer beneficial microbes and/or presence of 
pathobionts are associated with disease.2 Gut microbial diversity, measured via 
intestinal biopsies or fecal samples, is the number and abundance of distinct types of 
organisms found in the gastrointestinal tract and can be defined three ways.42 Alpha 
diversity is the average species diversity in a habitat; beta diversity is the diversity of 
species between two habitats; gamma diversity is the total diversity of a landscape, and 
is the combination of alpha and beta diversity.43 
Wong suggests that one advantage of having a greater microbial diversity could be to 
guarantee that metabolic functions are unaffected by changes in gut composition, 
whereby select microbes with similar functions can fill in for other microbes when a 
certain metabolic task needs to be performed.41 Valdes et al. proposed that diversity is a 
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good indicator of a ‘healthy gut’ in the sense that a diverse bacterial ecosystem will 
compensate for missing species.44  
When the composition of the gut microbiome is altered, such as a reduced diversity, a 
state of dysbiosis is present, or an imbalance of helpful and harmful bacteria.44 Low 
diversity can reduce resistance to pathogenic bacteria colonization, resulting in the 
expansion of harmful bacteria.45 Low diversity may also limit production of SCFAs since 
less bacteria of different types are available for fermentation.46 This dysbiosis may form 
the basis for the pathogenesis of disorders such as atherosclerosis, IBS, diabetes, and 
obesity.2 Notably, the imbalance of Firmicutes and Bacteroidetes has been a point of 
interest in gut research as varying levels of their abundance is associated with several 
disease states,47,48 namely obesity. The ratio of Firmicutes to Bacteroidetes in healthy 
infants, adults, and elderly are reported to be 0.4, 10.9, and 0.6 respectively.49 
Conversely, the F:B ratio varies among obese and lean individuals, with some studies 
reporting an increased F:B ratio in obesity,48,50,51 while others report the opposite 
relationship.52 Still, other studies have not found a correlation between BMI and the 
reported F:B ratio.53 While the ratio of F:B has been quantified in healthy populations, a 
taxonomic signature has yet to be established for unhealthy populations53 due to 
interindividual variability from differences in diet, lifestyle, and other factors.  
2.1.3.1    Atherosclerosis 
 
Dysbiosis has been identified as a strong risk factor for atherosclerosis, specifically 
through the production of trimethylamine-N-oxide (TMAO).22 TMAO inhibits reverse 
cholesterol transport and is formed from trimethylamine (TMA) which is a product of 
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gut microbial degradation of dietary precursors like l-carnitine and 
phosphatidylcholine.54 TMA is converted into TMAO in the liver by hepatic flavin 
monooxygenase 3.55 The gut microbiota that are thought to be involved in the initial 
conversion of l-carnitine and phosphatidylcholine to TMA include genera from the 
Firmicutes and Proteobacteria phyla including Clostridium spp.,Escherichia fergusonii, 
and Edwardsiella tarda.55 Furthermore, foods high in levels of l-carnitine and 
phosphatidylcholine, such as cheese, seafood, eggs, and red meat, can accelerate the 
development of atherosclerosis through microbial TMAO production.46 Gut microbiota-
mediated therapy has been proposed as one strategy to initiate inhibition of microbial 
TMAO synthesis.22 In this way, the gut microbiota behaves as a potential preventive 
agent of disease.  
2.1.3.2    Type 1 and Type 2 Diabetes 
 
The gut microbiota has also been implicated in other metabolic diseases, specifically 
diabetes. A study by Larsen et al. compared the composition of the intestinal microbiota 
in type 2 diabetics versus non-diabetics.47 The results found a significantly reduced 
(p=0.03) abundance of Firmicutes in the diabetic group (36.8% mean) compared to 
controls (56.4%), while Bacteroidetes was increased but not significantly in the diabetic 
group.47 Similar results were captured in a study comparing children with type 1 
diabetes to healthy children. The ratio of F:B in diabetic children (0.62) was significantly 
lower (p=0.001) than in healthy children (0.97).56 Both studies found that the F:B ratio 
correlated negatively and significantly to plasma glucose level and concluded that this 
ratio could be implicated in the glycemic level of the diabetic individuals. 
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2.1.3.3    Irritable Bowel Syndrome 
 
Altered gut communities are also seen in irritable bowel syndrome (IBS). In a review, 
Collins et al. discussed a variety of studies that repeatedly indicated an association 
between IBS, bacterial dysbiosis, and altered ratios of bacteria species.57 For example, 
when germ-free animals were colonized with fecal bacteria from patients with IBS 
compared to healthy controls, it resulted in maintenance of IBS symptoms in the germ-
free animal. The microbial dysbiosis of the IBS gut microbiota (i.e. more sulfate-reducing 
bacteria and less Bifidobacterium) along with hypersensitivity to colonic distension were 
maintained.58 In addition, several studies have seen an increase in the phylum 
Firmicutes and a decrease in the genus Bacteroides in IBS patients.57 Interestingly, 
triggers such as infection, stress, and antibiotic use initiate dysbiosis, which can alter the 
gut microbiota and may account for the characteristic symptoms of IBS over time.57 
Presence of IBS has implications for overall health as the condition may impact 
absorption of nutrients from the diet such that when the gut microbiota is disturbed, 
the body may become less efficient at converting food to usable products.  
2.1.3.4    Obesity 
 
Alterations in the human gut microbiota has also been identified as a risk factor for 
obesity, however, there is debate as to what capacity the gut microbiota contributes to 
the pathophysiology of obesity. That is, does obesity result from changes in the gut 
microbiota or does an obese status alter the gut microbiota? Nevertheless, several 
mechanisms have been proposed to account for this observation: (1) increased energy 
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harvested from the diet; (2) and changes in the intestinal barrier integrity linked to 
lipopolysaccharide (LPS).3  
In general, research indicates that there may be an association between the efficiency 
of the gut microbiota to extract energy from the diet and the development of obesity. 
Turnbaugh et. al. tested the mechanism behind this observation and found that when 
an obese microbiota was colonized into germ-free mice, it resulted in a significantly 
greater increase in total body fat.59 An increased concentration of butyrate and acetate 
were also seen in the gut, which was accompanied by significantly less energy remaining 
in their stools relative to the lean controls. Further, the obese microbiome had a 
substantial increase in genes that encoded enzymes involved in the breakdown of 
dietary polysaccharides.59 A suggested mechanism that linked the gut microbiota to this 
observation included provision of additional energy via conversion of dietary fiber to 
SCFAs.59  
Further, a human energy balance study investigated how diets that varied in caloric 
content impact the gut composition. Researchers found that alteration of the nutrient 
load (2400 kcal to 3400 kcal) resulted in rapid changes in the gut microbiota. A 20% 
increase in Firmicutes was associated with an increased energy harvest of ~150kcal and 
a 20% increase in Bacteroides was associated with a decreased energy harvest of 
~150kcal, suggesting the gut microbiota’s role in regulation of nutrient harvest.60  
Another proposed mechanism that links the gut microbiota to obesity is the presence of 
gut microbiota derived LPS.61 LPS is an inflammatory cell wall constituent of Gram-
 16 
negative bacteria that, when released due to cell division or death, can trigger an 
inflammatory cascade through Toll-like receptor-4 (TLR4), CD14, or NF-κB.37 Concerning 
obesity, a hypothesis is that when LPS leaks into circulation, TLR4 activates pro-
inflammatory pathways where cytokine expression induces altered metabolic function 
in adipose tissue.62 Evidence of this interaction has been explored in animals and 
humans. For example, infusion of LPS increased adipose tissue, insulinemia, and liver 
insulin resistance in mice.62 Additionally, in women, intestinal permeability correlated 
with visceral adiposity which was proposed to be related to LPS.63 Furthermore, a 
positive correlation between serum LPS and BMI, high triglycerides, and central 
adiposity was seen in young obese subjects.64 Together, these findings establish the 
possible relationship between LPS and obesity. However, since there remain questions 
relating the gut microbiota to health outcomes, it becomes increasingly more important 
to assess how both non-modifiable and modifiable factors like diet can alter the gut 
composition.    
2.1.4 Factors that influence the gut microbiota composition 
As previously mentioned, the gut microbiota seems to behave like a fluid ‘organ’ that 
continuously adapts to its environment. As such, there are non-modifiable factors like 
genetics, age, and hormones and modifiable factors like antibiotics, smoking, exercise, 
and diet that contribute to its composition and associated functions. 
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2.1.4.1    Non-modifiable factors that influence the gut microbiota 
 
2.1.4.1.1 Genetics 
 
While there is intraindividual variability in microbial communities, the human 
microbiota is generally stable at the phylum level with variation in phylum proportions 
between individuals.23 As such, genetic factors can govern these individual differences 
seen in the microbial populations. In a metagenomic study, researchers compared twin 
pair microbiotas across 1,000 fecal samples from the TwinsUK population. The study 
identified a variety of microbial taxa whose abundance was influenced by host 
genetics,65 indicating a link between host genetics and the gut microbiota. Nevertheless, 
the Bacteroidetes community was found to be shaped mostly by environmental 
factors.65 This suggests that some bacterial species are not heritable and are likely 
influenced by other factors. 
2.1.4.1.2 Age 
 
In addition to genetics, the composition of the microbiota changes with age (Figure 2). 
Microbes begin to colonize the gut shortly after birth and the bacteria continue to 
develop during breastfeeding as the oligosaccharides in breast milk encourage growth 
of Lactobacillus and Bifidobacterium.1 Once the baby switches to whole foods, the 
bacteria population shifts to favor bacteria that are needed to utilize fiber and other 
nutrients present in adult diets like Bacteroidetes and Firmicutes.1 While a variety of 
factors govern the composition of the gut microbiota–including genetics, puberty, 
ovarian cycle, pregnancy, and menopause – age is independently associated with the 
abundance of particular bacteria.1  
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The gut microbiota of infants (3wk-10mo), adults (25-45yr), and older adult (70-90yr) 
populations were sequenced with the following results: the infant gut microbiota was 
dominated by Bifidobacterium (Actinobacteria phylum), the adult gut microbiota was 
dominated by Firmicutes and Bacteroidetes, and the gut microbiota of older adults was 
dominated by Bacteroidetes and Firmicutes with a significant presence of E. coli 
compared to adults.49 The Bacteroides genus abundance was equivalent in all age 
groups.49 Total bacteria count was significantly lower in infants than in adults and 
seniors. Regarding the elderly population, the gut microbiota of 17 individuals from a 
geriatric department showed that the proportion of Bacteroidetes was significantly 
higher than in younger adults66 with similar findings reported by Claesson et al.67 
Reasons for the shifts seen in dominant bacterial species are unclear, but living situation 
(i.e. long-term care vs. community dwelling), altered diet,1 changes in digestive 
physiology, and reduction in transit time and digestive secretions have been 
postulated.49 
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Figure 2. Gut microbiota composition across the lifespan, Ottman, 2012.68 
2.1.4.1.3 Interaction between sex-related hormones and the gut microbiota 
 
In addition to age, a person’s sex may influence the gut microbiota. Considering the age-
related decline in sex hormones in both men and women, researchers have investigated 
the relationship between estrogen and the gut microbiota. Santos-Marcos et al. 
analyzed the gut microbiota in 17 premenopausal and 20 postmenopausal women and 
matched the two groups with men by age.7 Results showed a higher Firmicutes 
abundance in postmenopausal women versus premenopausal women, with a higher F:B 
ratio in postmenopausal women versus men. In addition, estradiol levels positively 
correlated with various bacteria classes and families. Interestingly, the researchers 
observed a lower relative abundance of SCFA producing bacteria, with lower butyrate 
and propionate metabolism, in postmenopausal versus premenopausal women.7 This 
has implications for women’s health as SCFAs have been associated with metabolic 
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health. Teixeira et al. found that a higher level of fecal SCFA in women correlated with 
metabolic syndrome risk factors with the authors suggesting that increased colonic 
fermentation may contribute to obesity.69 However, SCFAs have also been shown to 
regulate metabolic homeostasis through AMP-activated protein kinase70 while reducing 
postprandial free fatty acids and increasing satiety hormones.71 Therefore, it is unclear 
whether SCFAs contribute to metabolic risk or have the opposite effect by regulating 
appetite and energy homeostasis. Nonetheless, the researchers concluded that the 
differences in gut composition between men and women were influenced by hormonal 
status in women, and these differences may influence incidence of metabolic disease 
and their varied prevalence in men and women.7  
Interestingly, not only has estrogen been associated with the gut microbiota, but recent 
studies have shown that the gut microbiota is related to the development of CVD.37 
Research indicates that a transfer of fecal microbiota induces metabolic disease and 
obesity.37 The literature also suggests that an association exists between metabolic risk 
and gut microbiota changes in postmenopausal women.72 In one study, fecal DNA from 
obese postmenopausal women were analyzed and a systematic search was performed 
for bacterial genes associated with markers of insulin resistance, inflammation, and lipid 
metabolism. Researchers found that 114 metagenomic species correlated positively or 
negatively with the previously mentioned metabolic markers.72 The authors also found 
that diet modulated beneficial bacteria and emphasized the importance of focusing on 
diet when studying the link between gut microbiota and metabolic markers.  
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As it relates to CVD risk in general, women tend to experience weight gain, particularly 
in visceral adipose tissue, a few years prior to menopause,73 with postmenopausal 
women experiencing greater intra-abdominal fat versus pre-menopausal women.74 This 
physiological change coincides with losing 80% of their estrogen per year beginning the 
first year of menopause4 which is accompanied by shifts in adipose tissue deposition 
and expansion.74 Deposits of fat, especially in visceral adipose tissue, correlates to 
increased circulating adipokines which are implicated in insulin resistance and CVD.73 As 
such, women exhibit larger risk for metabolic disease as they age and with the transition 
to postmenopausal status5 which is proposed to result from reductions in circulating 
estrogen.6 
As such, the association between estrogen and metabolic risk may be explained by its 
interaction with the gut microbiota. The gut microbiota secretes β-glucuronidase which 
convert estrogens to their deconjugated form.6 The estrogen then interacts with 
estrogen receptors to elicit downstream effects resulting in physiological changes6 in the 
uterus, ovaries, bone, breast, liver, muscle, white adipose tissue, and colon.75 In effect, 
the gut microbiota encourages estrogen homeostasis. If gut dysbiosis and low gut 
diversity occur, a reduction in estrogen metabolism is possible due to a lack of estrogen 
metabolizing bacteria.6 Furthermore, a dysfunction in these physiological responses 
could contribute to disease states including CVD, obesity, MetS, endometriosis, 
polycystic ovary syndrome, and breast cancer.6 Proposed mechanisms for some of these 
conditions include low gut microbiota diversity and low circulating estrogen levels.6  
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Of interest, phytoestrogens may be able to reduce the risk of developing some of these 
conditions as they are a ligand for estrogen receptors.6 A recent article by Chen et al. 
explained that the microbiota can metabolize estrogen-like compounds to their active 
form, and these compounds can encourage proliferation of certain bacteria types.76 
Phytoestrogenic foods, including soy and lignins, are also shown to improve weight gain 
and are associated with a lower rate of overweight and obesity.76 Thus, phytoestrogens 
may play a role in preventing MetS through gut transformation. 
Furthermore, based on metagenomic analysis and the observed link between a decline 
in estrogen levels and metabolic health, postmenopausal women appear to be at an 
increased metabolic risk through both altered gut composition changes and the decline 
in estrogen that may be exacerbated by dysbiosis. Additionally, since a sedentary 
lifestyle, poor diet, and decreased mobility promote overweight and obesity, and 
combined with decreased estrogen levels in postmenopausal women, this age groups 
becomes a target for gut dysbiosis, MetS, diabetes, and CVD.  
2.1.4.2    Modifiable 
 
Of the factors that influence the gut microbiota, there are a few that may be modified. 
Such factors include the use of medications, especially antibiotics, smoking, physical 
activity level, and diet.  
2.1.4.2.1 Antibiotics 
 
It has been well established that although antibiotics are critical for killing harmful 
bacteria, beneficial bacteria are often destroyed along with the harmful bacteria being 
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targeted by the antibiotics. Use of antibiotics can suppress the commensal microbiota 
community within the gut along with their resistance against pathogens. This provides 
an opportunity for pathogenic bacteria to colonize the gastrointestinal tract.31 One 
deadly complication that can arise from antibiotic treatment is Clostridium difficile 
associated diarrhea, resulting in decreased microbial diversity.23  
2.1.4.2.2 Smoking 
 
Smoking has also been found to alter the gut microbiota. Capurso et al. found that 
smoking was associated with an increased rate of C. difficile infection while smoking 
cessation correlated with increased microbial diversity.77 The authors note, however, 
that confounders such as diet or an increase in body weight could have accounted for 
these changes.77 
2.1.4.2.3 Exercise 
 
While antibiotics and smoking have been negatively associated with the composition of 
the gut microbiota, evidence supports the positive role of exercise in gut health. In a 
mouse model, Luo demonstrated that moderate exercise increased gene expression for 
antimicrobial peptides accompanied by a lower degree of intestinal permeability and 
bacterial translocation.78 Further, Mika et al. demonstrated that the onset of exercise 
increased Bacteroidetes and decreased Firmicutes, a ratio associated with leanness.79 
Interestingly, O’Sullivan et al. explains that the vagus nerve controls gastrointestinal 
inflammation and exercise-induced activation of the nerve may encourage an anti-
inflammatory environment in the gut.80 Therefore exercise may influence the quantity 
and quality of the gut microbiota composition.80 
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2.1.4.2.4 Diet 
 
The diet is among the most powerful influencers of the gut microbiota composition. The 
following section will detail its impact on the gut microbiota. 
2.2 Dietary Effects on the Gut Microbiota 
Due to the diverse and variable diet of the average human, the gut microbiota must also 
diversify to satisfy the body’s metabolic needs. As such, much of the microbial diversity 
in the human gut is due to the microbial enzymatic capacity required to degrade 
nutrients.1 For instance, adequate insoluble fiber and nitrogenous protein consumption 
encourage bacterial fermentation in order to produce SCFAs.1 Additionally, dietary 
intake appears to be a significant short- and long-term regulator of the composition of 
the gut microbiota.81 However, only a small number of randomized controlled dietary 
intervention trials have been conducted in humans, of which, diets rich in fiber, fruit, 
and vegetables are associated with gut microbial activity that are linked to health 
benefits including increased abundance of probiotic bacteria and decreased intestinal 
inflammation.22 Thus, research seeks to isolate specific dietary patterns that increase 
microbial diversity while discouraging dysbiosis.  
2.2.1 Flexibility of the gut composition  
 
Diet can selectively and quickly alter the gut microbiota composition within days. One of 
the few studies in this area was by David et. al. who demonstrated how the gut 
microbiota can be rapidly altered by diet.81 For five consecutive days each, participants 
consumed two diets: a ‘plant-based diet’ rich in grains, legumes, fruits, and vegetables; 
and an ‘animal-based diet’ rich in meats, eggs, and cheeses. The animal diet observed a 
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significant increase in β-diversity after a single day but the gut microbiota reverted to 
their original structure two days after the diet intervention ended.81 This study showed 
that the human gut microbiota can rapidly switch between herbivorous and carnivorous 
bacterial profiles in order to maximize nutrient utilization. 
2.2.2 Diet-induced microbial diversity 
 
Diversity has been associated with different diet patterns. For instance, individuals 
consuming a plant-based diet versus a meat-based diet are shown to have a more 
diverse fecal microbiota composition.1 In fact, the phylogenetic diversity seen in the 
human gut is as follows: herbivore > omnivore > carnivore.82 Consuming a complex diet 
may increase levels of different types of bacteria and therefore increase SCFA 
production.46 With these considerations, if a diet-induced imbalance occurred, the 
microbiota can adapt, and the host will be less susceptible to disease and more resilient 
to stress.2  
2.2.3 Diet-induced microbial dysbiosis 
 
Normally, the gut microbial communities are in symbiosis with the host and perform 
their physiological functions. However, diet can lead to microbial dysbiosis in the gut. 
Diet-induced dysbiosis is associated with disturbed gut barrier functions, increased gut 
permeability, and increased plasma LPS concentrations, leading to low-grade 
inflammation that is associated with diseases such as obesity and MetS.29,62,83  
Regarding diet-induced dysbiosis, consuming excess dietary fat is shown to expose the 
body to potentially pro-inflammatory free fatty acids which can alter the gut 
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composition and increase plasma LPS.61 Mice fed a high-fat diet saw increased plasma 
LPS concentration by favoring the growth of certain Gram-negative bacteria resulting in 
increased liberation of LPS.62 Dysbiosis from decimation of Firmicutes and Bacteroidetes 
was associated with a disrupted intestinal barrier and LPS leakage across the gut wall 
due to reduced tight junctions or carried with fat that was absorbed from the gut.62  
2.2.4    Diet, Obesity, and the Firmicutes:Bacteroidetes ratio 
 
As mentioned previously, the human gut microbiota is composed of 50-80% Firmicutes 
and ~23% Bacteroidetes. An enlarged Firmicutes and reduced Bacteroidetes ratio (F:B) 
seem to represent the ‘bacterial trademark’ that characterizes obesity.90 As such, 
human and animal data support the theory that an increased ratio of Firmicutes to 
Bacteroidetes may contribute to the pathophysiology of obesity.  
At baseline, genetically obese mice are observed to have more Firmicutes than 
Bacteroidetes compared to their lean counterparts.51 In order to support this 
observation, as well as exclude that this ratio is restricted to genetically obese mice, 
studies have characterized the gut microbiota of high-fat fed mice. Murphy et al. found 
an increased Firmicutes and reduced Bacteroidetes proportion in mice fed a high fat 
diet.50 Similar findings were observed in two other high-fat diet mice trials.91,92 
In humans, adult female monozygotic and dizygotic twin pairs concordant for leanness 
or obesity revealed that the obese gut microbiota was associated with significantly 
lower Bacteroidetes and decreased diversity.93 This observation was analyzed in a diet 
and weight loss study with obese individuals who were assigned to one of two low-
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calorie diets: fat or carbohydrate restricted.48 At baseline, obese people had fewer 
Bacteroidetes (P<0.001) and more Firmicutes (P=0.002) than the lean controls. After 
calorie restriction, and over time, Firmicutes decreased significantly (p=0.002) and 
Bacteroidetes increased significantly (p<0.001) in obese participants. The results showed 
that irrespective of which two diets were assigned, the lower F:B ratio correlated with 
weight loss.48 This study indicates that certain bacteria may be implicated in obesity, 
and that manipulating the gut communities could be one approach to addressing 
obesity.  
In addition to the observed variation in the F:B ratio due to calorie restriction, diet 
pattern variations are shown to correlate with changes in the microbiota. For example, a 
lower ratio of F:B was observed in children from rural Africa consuming a plant-based 
dietary pattern versus European children consuming a western-style diet.87 The authors 
speculated that this change may be a mechanism to maximize energy uptake from their 
fiber-rich diet.87 This finding may explain why high fat diets in mice correlated with 
higher Firmicutes, since the Bacteroidetes phylum specializes in fiber degradation. 
While substantial evidence from robust studies support the association between the F:B 
ratio and obesity, conflicting reports exist in the literature. Schwiertz et al. characterized 
the fecal microbiota of overweight, obese, and lean adults and found that while the 
total amount of SCFA was higher in the obese group, consistent with the obesity 
hypothesis, they found a significantly higher abundance of Bacteroidetes than 
Firmicutes in overweight and obese subjects compared to lean subjects.52 In addition, 
one study found that the F:B ratio did not have a function in determining obesity, at 
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least at the phylum level, between lean and obese individuals.94 Further, the obesity 
associated Western diet83 has been shown to increase the Bacteroides genus within the 
Bacteroidetes phylum,85 but evidence also shows that obese individuals have a higher 
baseline F:B ratio.48   
While research has found an association between the gut bacteria composition and 
obesity, it is difficult to draw conclusions due to conflicting evidence. As such, the link 
between obesity and the gut microbiota may be more complicated than a shift in the 
Firmicutes:Bacteroidetes ratio. Therefore, since the link between the microbiota and 
obesity is inconclusive, it may be beneficial to examine how dietary patterns as a whole 
impact the gut to determine if an association persists across lifestyle factors.     
2.2.5 Diet patterns 
2.2.5.1    Western diet 
 
The Western lifestyle is often characterized by high fat and high sugar consumption83 
with a high incidence of chronic diseases including CVD and type II diabetes. Diet and 
gut health studies have linked the Western diet to unfavorable changes in the gut 
microbiota. In addition to the effects of high-fat diets already discussed, they can 
increase microbial production of deoxycholic bile acid (DCA) concentrations,95 which is a 
compound associated with liver cancer.96 Further, DCA was shown to significantly 
increase Firmicutes while decreasing Bacteroidetes,96 similar to those observed in mice 
fed high-fat diets. Diets high in saturated fat have also been found to increase numbers 
of pro-inflammatory microbes like Bilophila wadsworthia.97 Additionally, fat in lard form 
increased toll-like receptor activation and impaired insulin sensitivity versus 
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consumption of fish oil in mice. The authors concluded that an interaction between gut 
microbiota and the saturated fats led to these metabolic effects.86 
2.2.5.2    Plant-Based 
 
Compared to the western diet, plant-based diets are favored as they tend to produce 
end products like SCFAs that assist in gut and overall health. Vegetarian and vegan diet 
studies have substantiated the benefits of plant-based diets. In a pooled analysis of 5 
cohort studies, mortality from coronary heart disease (CHD) was reduced 24% in 
vegetarians compared with non-vegetarians.41 As such, plant-based diets may confer 
health benefits through modulation of the gut microbiota. A greater abundance of 
Bacteroidetes with a lower abundance of Firmicutes was observed when consuming a 
plant-based diet versus consuming a typical western diet.87 Conversely, compared to a 
Western diet, a Japanese diet (rich in soybean, radishes, cabbage, fish, seaweed and 
green tea) resulted in lower counts of Bacteroides genera and higher counts of 
Lactobacillus.98 Similar findings were observed in those following a vegetarian and vegan 
diet versus an omnivore control diet–both intervention groups saw significantly lower 
Bacteroides and Bifidobacterium counts, and vegans had significantly lower E. Coli and 
Enterobacteriaceae counts.99 The discrepancy seen in these plant-based studies may be 
explained by host genetics, different methodologies, or different microbiome profiling 
techniques. Nonetheless, this data indicates that different diet patterns, specifically a 
plant-based pattern, have the capacity to alter the gut microbiota which may or may not 
be related to positive health outcomes like reduced CHD. 
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2.2.5.3    Mediterranean 
 
Evidence also reveals that the Mediterranean diet may confer benefits to the host by 
altering the gut bacteria. As a diet that is plant-based, the Mediterranean diet is 
encouraged as a healthy eating pattern to establish and maintain good heart health.100 
Emphasis is placed on consuming high fiber, vegetables, fruit, grains, fish and poultry 
and minimizing intake of red meat, dairy, and sweets. Further, saturated fat intake 
should be limited in favor of monounsaturated fatty acids and polyunsaturated fatty 
acids.100 One study found that vegan, vegetarian, and omnivore participants whose diets 
aligned with the Mediterranean diet had increased fecal SCFAs, Firmicutes, and 
Prevotella (Bacteroidetes phylum), while low adherence to the diet was associated with 
elevated TMAO.101  
2.2.5.4    Probiotics 
 
Probiotics are live bacteria that, once consumed, benefit the host by colonizing the gut 
and exerting health promoting functions. Probiotics are prescribed to aid in restoring 
gut ecology in diseases such as IBS, IBD, enterocolitis, and infectious diarrhea.102 Various 
Lactobacilli and Bifidobacterium strains are recognized as probiotic agents and are 
thought to restore gut health.102 Their mechanisms vary depending on the strain of 
bacteria and the disease in which it is used to treat, and include maintaining host-
microbe interactions and pathogen growth, mucus secretion from goblet cells, 
maintaining epithelial barrier integrity, and producing antibacterial factors including 
activation of the host’s adaptive immune system.102 In a placebo-controlled randomized 
controlled trial (RCT), 60 overweight healthy adults consumed probiotics with various 
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strains of Bifidobacterium, Lactobacilli, and Streptococcus, which resulted in increases in 
concentration of the same bacteria.103 Additionally, yogurt with probiotic strains of 
bacteria reduced counts of enteropathogenic E. coli and Heliobacter pylori in-vitro.104  
2.2.6 Fruit  
Plant-based diets are shown to significantly alter the gut composition, and a large food 
item consumed in a plant-based diet is fruit. Fruit is currently the second most popular 
food item in the US, and by sales alone, berries, apples, bananas, grapes, and citrus rank 
in the top five highest grossing fruits, with berry sales ranking the highest at $3.02 
billion.105 Compared to other berries, strawberry consumption is much greater with an 
estimated per capita annual consumption of 7.9 pounds per year.106 With increased 
accessibility and per capita consumption, high levels of vitamins, minerals, and 
antioxidants, fruit has the potential to be an effective approach to improving health, 
specifically through the gut. 
Gut health has been associated with the concept of the ‘three P’s which include 
probiotics, prebiotics, and polyphenols.107 As such, research has investigated the effect 
of berries and berry polyphenols on the gut as they have received attention as 
antioxidants with properties to prevent chronic disease.108 The gut bacteria convert 
polyphenols into active and bioavailable metabolites, suggesting that variations in the 
gut microbiota can affect polyphenol activity108 and thus, may have short and long-term 
impacts on human health. 
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2.2.6.1    Previous work: polyphenols and gut health 
 
While relatively low in polyphenols compared to strawberries, several studies have 
assessed the potential for non-berry consumer fruits to modulate the gut microbiota. 
Shinohara et al. found that consumption of two apples per day increased Lactobacillus 
and Streptococcus while C. perfringens and Enterobacteriaceae decreased.13 Oranges 
and bananas have also been identified as a fruit with the ability to beneficially alter the 
gut microbiota. In a SHIME (Simulator of the Human Intestinal Microbial Ecosystem) 
vessel, Duque et. al. found that fresh orange juice significantly increased commensal 
bacteria species (from genera Lactobacillus, Enterococcus, Bifidobacterium, and 
Clostridium) while reducing Enterobacteria.14 Mitsou et al. assessed the impact of 
bananas on the gut microbiota and found that 60 days of banana consumption resulted 
in a non-significant increase in Bifidobacterium levels in the banana group.15 
In addition to whole non-berry fruit, two studies have investigated the influence of red 
wine polyphenols on the human gut. Queipo-Ortuno et al. had 10 healthy men consume 
272 ml a day of red wine (797.86 mg gallic acid equivalents [GAE] of total phenols), de-
alcoholized red wine (733.02 GAE of total phenols), or gin, each for 20 days.9 Red wine 
polyphenols significantly increased Proteobacteria, Fusobacteria, Firmicutes, and 
Bacteroidetes, while the de-alcoholized red wine increased Fusobacteria but 
significantly decreased Firmicutes and Bacteroidetes. The authors concluded that red 
wine polyphenols exhibit a prebiotic effect. Moreover, changes in cholesterol and C-
reactive protein concentrations were linked to changes in Bifidobacterium numbers.9 
With the same diet supplement, but in participants with MetS, Moreno-Indias et al. 
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found that red wine and de-alcoholized red wine, consumed for 30 days each, 
significantly increased the number of Bifidobacterium and Lactobacillus while 
decreasing Bacteroides, E. coli, and Enterobacter spp.10 The polyphenols also improved 
various metabolic markers. The authors concluded that the changes in the MetS 
participants’ gut microbiota could be responsible for the improvement in the MetS 
markers.10 
Polyphenols in the form of fruit extracts can also impact the gut microbiota. Molan et al. 
assigned thirty healthy men and women to consume blackcurrant extract powder with 
lactoferrin and lutein or to consume only blackcurrant extract powder in capsule form 
four times per day for two weeks.11 Both forms of blackcurrant significantly increased 
Bifidobacterium and Lactobacilli population sizes while Clostridium spp. and Bacteriodes 
spp. decreased significantly. The authors concluded that blackcurrant powder can act as 
a prebiotic.11 Similarly, in a controlled trial, Li et al. instructed 20 normal weight healthy 
male and females to consume a daily dose of 1000 mg of pomegranate extract (680 mg 
GAE of total phenols), equivalent to 8 oz of pomegranate juice, for 4 weeks.12 
Consumption of pomegranate extract significantly increased Actinobacteria with a 
significant decrease in Firmicutes. The authors proposed that these results may have 
implications in weight maintenance and insulin resistance by changing the ratio of 
Firmicutes to Bacteroidetes.12 
Numerous studies have investigated the effect of whole berries on the composition of 
the gut microbiota. Specifically, red berries have been analyzed in several controlled 
diet intervention trials. Vendrame et al. investigated the daily consumption of a wild 
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blueberry (WB) freeze-dried powder drink in a RCT, crossover, diet intervention.16 
Twenty male volunteers with at least one risk factor for CVD consumed a 250 mL WB 
drink (25g of WB freeze-dried powder; 375 mg anthocyanins) or a placebo drink for 6 
weeks. Blueberry polyphenols significantly increased Bifidobacterium spp. after the 
blueberry treatment with increased Lactobacillus acidophilus after both treatments.16  
In another diet intervention, Ige et al. assigned four female volunteers to consume 600 
ml of blueberry puree per day for 29 days.17 Before stool analysis, the samples were 
incubated for Lactobacillus spp. and Enterobacteriaceae spp. The authors found that 
consumption of blueberry puree resulted in new strains of Lactobacillus bacteria while 
other Lactobacillus strains resisted the anti-oxidant properties of the blueberry.17  
In addition to blueberries, raspberries have also been targeted as a fruit rich in 
polyphenols with the potential to impart health benefits through the gut. In a free-living 
diet intervention trial, Gill et al. instructed 10 male participants to consume 200 g of 
raspberry puree (296 mg gallic acid equivalents) per day for 4 days.18 Following stool 
sample analysis, it was observed that the raspberry supplementation resulted in small, 
yet insignificant changes to the microbiota composition.18  
In addition to assessing the impact of single fruits on the gut microbiota composition, 
one researcher investigated the synergistic effect of a combination of whole red berries 
on the gut. Puupponen-Pimia et al. assigned 32 male and female participants with MetS 
to consume either 300 g of fresh berries (70.7 mg anthocyanins) comprised of 100 g 
strawberry puree, 100 g frozen raspberries, and 100 g frozen cloudberries or to restrict 
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berry consumption for 8 weeks.19 Participants maintained their habitual diet but 
restricted consumption of berries to 80 g/day. Stool samples were collected during five 
separate laboratory visits and were analyzed for microbial diversity. Results showed that 
4 subjects in the berry group saw insignificant changes to their bacterial profile while 13 
participants saw no change. Further, no significant differences in diversity of 
predominant bacterial populations were seen between groups.19  
Compared to the top fruits consumed in the US, as reviewed in the studies above, 
berries, including strawberries, contain a wide spectrum of beneficial ingredients, and 
combined with their affordability and accessibility, give them the potential to improve 
health through the gut.  
2.3 Strawberries 
The strawberry (genus: Fragaria) is a member of the Rosaceae family and is widely 
consumed in the Mediterranean diet due to their diverse nutritional composition.109 
While researchers have just recently begun studying the health benefits of strawberries, 
the strawberry dates back to the first century A.D. and have been eaten in small 
quantities by people worldwide since ancient times.110 It wasn’t until the 1300s when 
the French transplanted the wild strawberry into the garden that strawberries began to 
be cultivated and widely consumed. The spread of this berry was slow and was not fully 
appreciated until the end of the 18th century when the Chilean strawberry was crossed 
with the Virginia strawberry, giving rise to the modern strawberry known today.110    
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2.3.1 Biochemical composition 
The unique biological composition of strawberries yields health benefits through their 
high content of essential nutrients and beneficial phytochemicals. They exert their 
effects on human health by impacting lipid profiles, insulin response, immunological 
responses, and pathogen growth, and thus have implications for heart and gut health.109 
The nutrients in strawberries that are likely to have the greatest impact on improving 
human health are fiber, vitamin C (see appendix A for strawberry nutrient composition), 
and various polyphenols, namely flavanoids, hydrolyzable tannins, and phenolic acids109 
(Figure 3) (see appendix B for strawberry polyphenol composition). Briefly, as a 
functional component of strawberries, fiber slows digestion and can control calorie 
intake through satiation.111 Apart from their role in lowering LDL-CH, increasing insulin 
sensitivity, and aiding in gut motility,112 fiber also improves gut health when degraded to 
SCFAs. Vitamin C, a known antioxidant, participates in gene expression and is a cofactor 
in enzymatic reactions throughout the body including collagen, carnitine, and 
neuropeptide synthesis.113 Various cohort studies show that vitamin C is associated with 
lower risk for hypertension, stroke, and coronary heart disease.113 The impact of 
strawberry polyphenols on gut health are specific to each subgroup and will be 
discussed individually in the following sections. 
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Figure 3. Main classes of strawberry polyphenols. 
2.3.2 Effects on heart health 
Recent literature has shown that strawberries exhibit beneficial effects on heart health. 
While the mechanism is still unknown, strawberry polyphenols significantly lowered 
triglycerides and oxidized LDL-CH (low density lipoprotein-cholesterol) after 
hyperlipidemic adult men and women consumed a high-fat meal.114 Additionally, 
strawberries have been found to significantly decrease total and LDL-CH in adult men 
and women with MetS115 while significantly decreasing serum cholesterol levels in 
overweight and obese men and women.116 In addition, strawberries appear to exert a 
protective effect against the development and/or progression of inflammatory 
conditions such as CVD. For instance, in various LPS treated cell models, including 
mouse macrophages and human fibroblast cells, strawberries were shown to counteract 
LPS induced oxidative stress by reducing ROS and nitrite levels; protecting against DNA 
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damage and lipid and protein oxidation; and reducing pro-inflammatory cytokines (IL-1β 
and IL-6) while increasing the anti-inflammatory cytokine IL-10.117,118   
2.3.3 Effects on gut health 
As a rich source of polyphenols, another way strawberries impart their health benefits is 
through modulation of the gut microbiota. Polyphenols undergo metabolism by the gut 
microbiota therefore producing metabolites that are more readily available to the 
body.107 Colonic fermentation of polyphenols yield numerous absorbable 
biotransformation products including phenylacetic, phenylpropionic, phenylbutiric, 
valeric acids, valerolactone, and urolithin A and B.119  
Once ingested, polyphenols have been shown to promote the growth of bacteria 
including Lactobacillus and Bifidobacterium.107 In this way, polyphenols exhibit prebiotic 
like effects and can be viewed as relevant modulators of beneficial microbiota.108 Such 
effects have been documented in a variety of in-vitro and clinical studies with 
polyphenol-rich foods, many of which have been detailed in the above text [Section 
2.2.2]. Further, recent studies have shown a positive association between consuming 
polyphenol-rich foods and a lower F:B ratio.90,120,121 
2.3.4 Phytochemicals 
As previously mentioned, strawberries derive some of their health benefits from 
nutritive compounds. Strawberries also consist of nonnutritive phytochemical 
compounds that impart their benefits through the gut. Phytochemicals are plant 
metabolites that enable the plant to overcome environmental threats while controlling 
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growth and reproduction.122 Such effects have prompted researchers to identify 
phytochemicals with therapeutic potential in humans, including those found in 
strawberries. The major phytochemicals present in strawberries include anthocyanins, 
flavonols, flavanols, ellagitannins, and hydroxycinnamic/hydrobenzoic acids.111 
2.3.4.1    Anthocyanins 
 
Anthocyanins represent a major phytochemical group in strawberries with more than 25 
different anthocyanin pigments reported including pelargonidins and cyanidins.109 A 
meta-analysis by Giampieri et al. details the health benefits of strawberries and explains 
that anthocyanins avoid absorption in the small intestine and subsequently pass 
through to the colon where bacteria convert the chemical into smaller phenolic acids.123 
Regarding their impact on human health, one study found that anthocyanins exerted an 
anti-inflammatory effect in human epithelial cells infected with Heliobacter pylori 
thereby ameliorated gastric mucosal damage.124 Another study found that one month of 
consuming 500 g of strawberries in healthy individuals was associated with 
improvement of the serum lipid profile.125 Therefore, the intake of anthocyanin-rich 
strawberries could potentially prevent gastrointestinal distress and the pathogenesis 
CVD.  
2.3.4.2    Flavonols 
 
Another bioactive compound in strawberries are flavonols which consists of quercetin 
and kaempferol compounds.111 Members of the flavonoid class are primarily degraded 
by Clostridium and Eubacterium.119 Quercetin has been shown to exhibit prebiotic and 
anti-microbial potential by stimulating Lactobacillus spp. growth and inhibiting E. coli119 
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while enhancing the intestinal barrier function.126 Research also reported the ability of 
quercetin to attenuate the increase in the F:B ratio in high-fat fed mice.90 
2.3.4.3    Flavanols 
 
Flavanols consist of compounds including catechins and proanthocyanidins.111 
Proanthocyanidins are found in the strawberry flesh111 and, like anthocyanins, are 
processed by the gut bacteria to produce phenolic acids.123 In a double-blind crossover 
RCT, cocoa flavanols increased Bifidobacterium and Lactobacilli populations and 
decreased Clostridia counts.127 Like flavonols, flavanols may also impart health benefits 
through prebiotic activity.   
2.3.4.4    Hydrocinnamic/Hydrobenzoic acids 
 
Hydroxycinnamic hydroxybenzoic acids exist within the phenolic acid group and include 
caffeic acid, gallic acid, and coumaric acid.109 Of the available research, hydrocaffeic acid 
has been shown to exhibit anti-inflammatory activity in vitro and in vivo, eluding to their 
anti-cancer properties.128 
2.3.4.5    Ellagitannins 
 
Hydrolyzable tannins represent the second major phenolic class in strawberries. Within 
this class, ellagitannins are the only major group.111 Ellagitannins are comprised of 
various compounds including ellagitannin, ellagic acid, ellagic acid glycosides, sanguiin 
H-6, and galloyl-bis-HHDP-glucose.109 Ellagitannins are only found in cloudberry, 
raspberry, rose hip, sea buckthorn, and strawberry. Notably, strawberries exhibit 
antimicrobial properties through the activity of ellagitannins.109 An in-vitro study found 
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that phenolic extracts from strawberries elicited antimicrobial activity against B. cereus, 
H. pylori, C. jejuni, and C. albicans, thereby revealing that ellagitannins are principally 
involved in pathogen suppression.109   
Of specific interest, the gut microbiota can convert ellagic acid into bioavailable 
urolithins; a class of compounds shown to exhibit anti-inflammatory and 
anticarcinogenic effects.129 The bacteria Gordonibacter urolithinfaciens and other 
unknown species are involved in the conversion of ellagic acid to urolithin A, isourolithin 
A, and urolithin B.107 Urolithins are produced in various concentrations depending on 
the individual which may have implications for health.129 In a study looking at microbial 
metabolism of ellagic acid, three different urolithin phenotypes were consistently 
observed in human intervention trials: ‘Phenotype A: produce only urolithin A’, 
‘Phenotype B: produce isourolithin A and/or urolithin B in addition to urolithin A’, and 
‘Phenotype 0: no detections of urolithins’.129 These observations were made 
independent of age, gender, BMI, health status, or amount and type of ellagitannin food 
ingested. However, phenotype B was observed in individuals with MetS or colorectal 
cancer associated with dysbiosis.129 Based on these data, the gut microbiota 
composition may modulate urolithin production and bioavailability, therefore targeting 
the gut may be beneficial when considering the health benefits of ellagic acid.  
2.4 Conclusion 
Due to their popularity, accessibility, and high polyphenol content compared to other 
popular consumer fruits, strawberries have recently emerged as a functional food which 
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are implicated in disease prevention and health promotion.109 Specifically, the phenolic 
compounds found in strawberries stimulate the growth of commensal and probiotic 
strains of bacteria,8 and thus, may be an alternative to pharmaceutical interventions for 
improving gut health. Furthermore, recent research has linked the gut to a variety of 
cardiometabolic disease states, and thus, diet modification may be one method to 
promote health through modulating the gut bacteria. 
To date, research has not assessed the potential effect of a daily, modest consumption 
of strawberries (~1 cup/d) on the gut microbiota in overweight, postmenopausal 
women. Research has shown that CVD risk increases in women with age and the 
transition through menopause.5 Since research has shown a significant relationship 
between diet, the gut microbiota, and risk factors for cardiovascular and metabolic 
disease,2 targeted dietary interventions may be effective at improving cardiometabolic 
health in postmenopausal women through the gut. Therefore, to add to the body of 
research, and reduce the gap in the literature, the aim of this study is to evaluate the 
effects of strawberry consumption on gut health in postmenopausal women. 
 
 
 
 
 
 
 43 
3. MATERIALS AND METHODS 
 
3.1 Objectives 
Given the potential role of strawberries on gut health, and the association between gut 
bacteria and health outcomes, the objectives of this study were to determine the impact 
of daily strawberry consumption on specific gut health changes in overweight, 
postmenopausal women. Specifically, we identified if 13 g/d of FDSP would impact the 
following objectives: 
• Objective #1:  Firmicutes to Bacteroidetes ratio. 
• Objective #2: Bacterial diversity. 
• Objective #3: Relative abundance of Lactobacillus and Bifidobacterium.  
These objectives were based on the hypothesis that polyphenol intake may modulate 
the gut microbiota by influencing the growth of specific bacteria linked to host health. 
Therefore, the hypothesis is that daily consumption of FDSP, equivalent to 1 cup of fresh 
strawberries, will beneficially affect the composition of the gut microbiota by reducing 
the ratio of Firmicutes to Bacteroidetes, increasing microbial -diversity, and increasing 
the relative abundance of probiotic Lactobacillus and Bifidobacterium bacteria.  
3.2 Participants and Recruitment 
Participants were recruited from San Luis Obispo and Fresno counties through flyers, 
digital, and social media advertisements. Ten weight-stable (≤5% body weight change in 
previous 6mo), overweight (BMI 25-34.9 kg/m2), postmenopausal women (age ~45-70y; 
>12mo since last menstrual cycle) volunteered to participate in this study (Figure 5). 
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Participants were generally healthy and had not altered their physical activity levels for 
at least 6 months prior to the start of the study. Exclusion criteria included:  
1. Smoking or tobacco use (current or within the past 6 months);  
2. >7 alcoholic beverages/wk OR > 2 servings/day (beverage = 12 oz. beer, 5 oz. 
wine, 1.5 oz. distilled spirits);  
3. Currently following an energy-restricted (intentionally reducing energy intake to 
lose weight) or low-fat (<20% energy from fat) diet; 
4. Regular physical activity level >180min/wk of moderate to high intensity physical 
activity, excluding activities normally required for participant’s occupation;  
5. Planning to begin engaging in moderate to high intensity physical activity 
>90min/wk after being sedentary for >6 months; 
6. Use of medications or supplements that could interfere with the outcomes of 
this study (including probiotics and antibiotics);  
7. Unwilling or unable to consume <5 serv/wk of soy (specifically tofu and 
soybeans), green tea, or high-cocoa (>60%) dark chocolate, combined;  
8. Unwilling or unable to avoid consuming more than 1 serving of red wine per 
week;  
9. Allergic to strawberries. 
3.3 Screening 
Volunteers were screened through a two-step process: 1. Completion of an online or 
phone eligibility questionnaire and 2. In person verification of BMI. The study website 
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was hosted on Cal Poly’s Drupal Secure Forms website which included a link to a page 
with the eligibility screening questionnaire. If the volunteers were eligible based on the 
screening questionnaire, they were invited to come to the Cal Poly Human Nutrition Lab 
for an in-person screening to verify BMI. Following the in-person screening, eligible and 
interested individuals were asked to read and complete the informed consent form and 
complete a health history questionnaire in order to participate in the study.   
3.4 Experimental Design 
This study was a 5-week free-living diet intervention trial consisting of a 3-week 
washout (Figure 4) followed by a 2-week diet intervention treatment.  
 
 
 
  
 
 
 
 
 
 
Figure 4. Study flow diagram. 
3.5 Intervention 
3.5.1 Washout 
Once informed consent was obtained, each participant completed a 3-week washout 
phase which required the participant to avoid consuming dietary sources high in 
polyphenols and probiotics, including, but not limited to foods or beverages with fresh, 
frozen, or processed berries. Participants were also asked to consume ≤5 servings per 
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week of tofu, soybeans, green tea, and high-cocoa chocolate. A list of foods to avoid was 
given to participants to reference for the duration of the study (see appendix C). 
3.5.2 Health Check #1 and #2 
After the participants successfully completed the washout, they proceeded to the first 
Health Check. “Health Check #1” was a baseline set of assessments including 
anthropometrics, two fecal collections, and 3-day diet and physical activity records. 
After the washout, participants began the intervention and then ended the study with 
“Health Check #2”. The same health check assessments that were performed in Health 
Check #1 were performed during Health Check#2. 
3.5.3 Supplement intervention 
For 2-weeks during the supplement intervention, participants consumed 13 g/d of FDSP, 
equivalent to ~125 g fresh strawberries (~1 cup fresh), in 4-8 oz of water every day. To 
ensure palatability, participants were given the option to mix into a smoothie form with 
banana, orange juice, or ice (one participant mixed strawberry powder with almond 
milk). The supplement composition is as follows: 
Freeze-dried strawberry powder – 13 g FDSP; composed of dehydrated strawberries 
representing a mixture of cultivars commonly available to consumers in the United 
States as fresh and frozen berries (See Appendix A and B for nutrient composition and 
polyphenol composition of FDSP). 
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3.6 Assessment Procedures 
A brief schedule of assessments completed by the participants is shown below (Table 1). 
A week-by-week breakdown of the study activities was given to participants along with 
a calendar that depicted when to collect the stool samples and when to complete the 3-
day weighted diet and physical activity records. 
Table 1. Assessments. 
 
 
 
 
 
 
 
 
 
*PA=Physical activity 
This study was approved by Cal Poly Institutional Review Board (IRB#2018-277-CP). 
3.6.1 Anthropometrics 
Both body weight and height were assessed at baseline. Weight was determined using a 
Seca scale (seca 876, Seca GmbH & Co. KG, Hamburg, Germany). Height was determined 
using a Seca stadiometer (seca 217, Seca GmbH & Co. KG, Hamburg, Germany). Body 
weight was assessed after the 3-week washout and following the 2-week intervention 
period. BMI was calculated from weight and height.  
3.6.2 Diet, Physical Activity, & Health History 
Diet, PA, and health history was assessed at baseline using a Health History 
Questionnaire. Three-day weighed food and PA records (see Appendix D and E) were 
Study Phase 
Assessment Time 
Point (Wk) Assessments* 
Screening 0 Anthropometrics, Health History Questionnaire 
Washout 3 Anthropometrics, Gut Microbiota, Diet & PA 
Supplement 
Intervention 
5 
Anthropometrics, Gut 
Microbiota, Diet & PA 
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used to document, track, and assess dietary intake and PA and were performed within 
the week before each health check. Participants used a tracking log to document berries 
and other foods high in probiotic and polyphenolic that may have been consumed 
throughout the study. Diet and PA data were analyzed using ESHA Food Processor 
(v10.14.2). 
3.6.3 Gut Microbiota Health - Fecal Analysis  
Following the washout and supplement intervention, participants provided 2 fecal 
samples over a 4-7 day period during the last week of the washout phase and within the 
two days following the end of the supplement intervention. Participants were provided 
with uBiome’s stool Gut ExplorerTM collection kit (Figure 5) that included instructions 
and return procedures along with all necessary supplies. All participants were given 
gloves to reduce the risk of fecal contamination. The kit is equipped with the following 
materials: a collection vial, swabs, a replacement vial, a sample return bag in which the 
sample is placed before putting in the return mailer, and a return mailer (with prepaid 
postage by uBiome). All participants collected their stool samples according to protocol 
outlined in the kit. Briefly, following a bowel movement, participants were instructed to 
use a sterile swab to transfer a small amount of fecal material into a vial containing a 
proprietary lysis and stabilization buffer that preserves the DNA for transport to the 
uBiome research facility at ambient temperatures130. Participants obtained the stool 
sample by wiping the swab to the soiled toilet paper and then swirled the swab in the 
vial for one minute. After collection, participants mailed their de-identified samples to 
the uBiome research facility for DNA extraction and 16S rRNA gene sequencing. 
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Figure 5. uBiome ExplorerTM gut kit. 
3.6.4 DNA extraction and 16S rRNA Gene Sequencing 
According to uBiome protocol, samples were lysed using bead-beating, and microbial 
DNA was extracted in a class 1000 clean room by a guanidine thiocyanate silica column-
based approach using a liquid-handling robot. Polymerase chain reaction (PCR) 
amplification of the 16S rRNA genes was performed using universal V4 primers (515F: 
GTGCCAGCMGCCGCGGTAA and 806R: GGACTACHVGGGTWTCTAAT). Samples were 
barcoded with a unique combination of forward and reverse indexes allowing for 
simultaneous processing of multiple samples. PCR products were pooled, column-
purified, and size-selected through microfluidic DNA fractionation. Consolidated 
libraries were quantified by quantitative real-time PCR using the Kapa Bio-Rad iCycler 
qPCR kit on a BioRad MyiQ before loading into the sequencer. Sequencing was 
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performed in a pair-end modality on the Illumina NextSeq 500 platform rendering 2 x 
150 bp pair-end sequences.130  
3.7 Compensation 
Upon completion of all study requirements, participants were compensated with a $50 
gift card to Target or Amazon based on their preference.  
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4. RESULTS 
4.1 Participants 
A total of 31 participants completed the online screening questionnaire, 12 of whom 
qualified for the study based on the questionnaire (Figure 6). At California Polytechnic 
State University-SLO, 5 participants were screened to confirm their final eligibility, and 
each qualified. At the Eye Medical Center of Fresno, 7 participants were screened to 
confirm their final eligibility, and each qualified. Of the 12 total participants who 
qualified, 10 completed the study: 4 from San Luis Obispo (SLO) and 6 from Fresno. 
Reasons for participant drop-out included health concerns and stomach discomfort from 
the supplement. 
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Figure 6. Consort flow diagram of participant participation. 
 
Completed questionnaire (n=31) 
Screened for eligibility (n= 12) 
Excluded (n= 0) 
• Not meeting inclusion criteria 
(n= 0) 
• Declined to participate (n= 0) 
• Other reasons (n= 0) 
Began intervention (n= 12) 
• Received allocated intervention 
(n=11) 
• Did not receive allocated intervention 
(n=1) (due to health concerns) 
Follow-Up 
Lost to follow-up (n=0) 
Discontinued intervention before end of study (n=2) 
• 1=early withdrawal due to health concerns 
• 1=early withdrawal due to intolerance to FDSP 
Analysis 
Intervention 
Analysed (n= 10) 
• Excluded from analysis (n=2) 
o 2=did not complete intervention 
 
Enrollment 
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Baseline characteristics are shown in Table 2. None of the characteristics were 
significantly different between participants from SLO or Fresno. 
Table 2. Participant baseline characteristics, mean ± SD. 
Characteristic SLO (n=4) Fresno (n=6) Mean (n=10) P-value 
Age, years 59 ± 6.27 61.5 ± 11.11 60.5 ± 9.13 0.70 
Body weight (kg) 75.9 ± 9.98 73.91 ± 11.88 74.71 ± 10.61 0.79 
BMI (kg/m2) 31.7 ± 4.05 28.83 ± 3.03 29.98 ± 3.58 0.23 
SLO=San Luis Obispo 
BMI=Body Mass Index 
4.2 Measures of Adiposity 
Results for body weight and BMI among all 10 participants are shown in Table 3.  
Table 3. Measures of adiposity at baseline, week 3, and week 5, (n=10). 
Measure of 
Adipositya 
 
Baselineb 
 
Week 3b 
 
Week 5b 
 
P-value 
Body weight (kg) 74.71 (3.30) 74.15 (3.30) 74.39 (3.30) 0.22 
BMI (kg/m2) 29.98 (1.11) 29.76 (1.11) 29.80 (1.11) 0.26 
aParticipants were categorized as a random effect 
bLeast squares mean (standard error of the mean) 
BMI=Body Mass Index 
There were no significant differences in body weight between baseline and subsequent 
weeks. Average body weight at baseline was 74.71 kg and was 74.15 kg and 74.39 kg on 
week 3 and week 5 respectively.  
Similarly, there were no significant differences in BMI between baseline and subsequent 
health checks. Average BMI at baseline was 29.98 kg/m2 and was 29.76 kg/m2 and 29.80 
kg/m2 at the end of week 3 and week 5 respectively.  
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4.3 3-Day Diet Record 
Results from the 3-Day Diet records including calorie count and macronutrient and 
micronutrient intake are show in Tables 4-7 below.  
Table 4. Calorie count and macronutrient intake, (n=10). 
Nutrient Week 3a Week 5a P-value 
Calories (kcal) 1634.39 (148.82) 1618.02 (145.65) 0.78 
CHO (g) 202.83 (20.54) 205.31 (15.40) 0.84 
Protein (g) 57.48 (5.38) 60.37 (7.38) 0.48 
Fat (g) 68.34 (6.39) 63.11 (8.23) 0.28 
Fiber (g) 20.92 (2.16) 19.14 (1.93) 0.34 
Fiber (per 1000 kcal) 13.01 (0.93) 12.11 (1.12) 0.54 
Sugar (g) 66.02 (6.72) 80.49 (7.51) 0.03b 
aLeast squares mean (standard error of the mean) 
bSignificant value (p≤0.05) 
CHO=Carbohydrate 
There were no significant differences in calories, carbohydrates, protein, fat, or fiber 
between week 3 and week 5. There was a significant difference in sugar intake between 
week 3 and week 5 (p=0.03). Sugar intake at the end of week 3 was 66.02 (6.72) g while 
at the end of week 5 increased to 80.49 (7.51) g. Sugar intake was not significant 
(p=0.27) when the sugar from the FDSP (7.96 g) was removed from the analysis.
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Figure 7. Participant calorie, CHO, protein, and fat intake at week 3 and week 5. 
 56 
 
 
Figure 8. Participant fiber and sugar intake at week 3 and week 5.
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The calorie count and macronutrient intake varies between participants from week 3 to 
week 5 (Figure 7 and 8). 
Table 5. Vitamin intake, (n=10). 
Vitamin Week 3a Week 5a P-value 
A-RAE (μg) 464.49 (66.61) 471.76 (65.38) 0.94 
D (μg) 1.91 (0.38) 2.45 (0.45) 0.19 
E (mg) 8.01 (2.55) 6.39 (0.99) 0.40 
K (μg) 85.38 (22.95) 47.84 (14.19) 0.20 
B1 (mg) 0.97 (0.22) 0.92 (0.20) 0.43 
B2 (mg) 1.26 (0.18) 1.33 (0.20) 0.46 
B3 (mg) 12.02 (1.77) 13.70 (2.66) 0.33 
B5 (mg) 3.11 (0.34) 2.70 (0.44) 0.39 
B6 (mg) 1.07 (0.16) 1.19 (0.20) 0.33 
Biotin (B7) (μg) 12.16 (3.68) 7.76 (2.54) 0.13 
Folate (B9) (μg) 300.13 (55.16) 263.73 (38.73) 0.36 
B12 (μg) 1.79 (0.30) 3.04 (0.56) 0.03b 
C (mg) 84.83 (18.23) 106.22 (11.39) 0.36 
aLeast squares mean (standard error of the mean) 
bSignificant value (p≤0.05) 
There were no significant differences in any vitamin except for vitamin B12 (p=0.03). 
The average vitamin B12 intake at the end of week 3 was 1.79 (0.30) μg and was 3.04 
(0.56) μg at the end of week 5.  
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Table 6. Mineral intake, (n=10). 
Mineral Week 3a Week 5a P-value 
Calcium (mg) 625.02 (93.66) 641.46 (104.92) 0.72 
Chromium (μg) 0.59 (0.21) 1.04 (0.37) 0.12 
Copper (mg) 0.91 (0.22) 0.63 (0.11) 0.08 
Fluoride (mg) 1.52 (0.56) 1.02 (0.29) 0.46 
Iodine (mcg) 38.33 (8.66) 34.25 (9.94) 0.35 
Iron (mg) 12.30 (3.03) 12.61 (3.01) 0.71 
Magnesium (mg) 226.71 (47.02) 180.45 (26.18) 0.19 
Manganese (mg) 2.25 (0.95) 1.33 (0.27) 0.27 
Molybdenum (mg) 15.36 (6.44) 7.67 (2.84) 0.11 
Phosphorus (mg) 805.94 (157.82) 734.79 (123.41) 0.51 
Potassium (mg) 1772.9 (163.31) 1696.42 (148.07) 0.69 
Selenium (μg) 50.89 (9.23) 45.08 (6.37) 0.47 
Sodium (mg) 2165.8 (271.40) 2193.65 (274.56) 0.89 
Zinc (mg) 6.13 (1.22) 6.28 (1.04) 0.82 
aLeast squares mean (standard error of the mean) 
There were no significant differences in mineral intake between week 3 and week 5. 
Results for fruit and vegetable intake are shown in Table 7 below. 
Table 7. Fruit and vegetable intake, (n=10). 
Food Group Week 3a Week 5a P-value 
Fruit (cup equivalent) 0.87 (0.21) 2.09 (0.28) 0.0014b  
Vegetable (cup equivalent) 1.56 (0.32) 1.22 (0.27) 0.43 
aLeast squares mean (standard error of the mean) 
bSignificant value (p≤0.05) 
There was a significant difference in fruit intake (p=0.0014) between week 3 and week 
5. Fruit intake was not significant (p=0.24) when the 1 serving of fruit from the FDSP was 
removed from the analysis. There was no significant difference in vegetable intake 
between week 3 and week 5. 
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4.4 Gut Health 
Strawberry consumption did not result in a significant change to the F:B ratio or -
diversity. Likewise, Bifidobacterium and Lactobacillus abundance did not significantly 
change. 
4.4.1    Bacteria abundance and alpha diversity 
 
Table 8 and the following graphs (Figure 8-10) depict changes in Firmicutes, 
Bacteroidetes, Bifidobacterium, Lactobacillus, and -diversity between week 3 and 
week 5. 
Table 8. Bacteria abundance and alpha diversity, (n=10). 
Bacteria Week 3a Week 5a P-value 
Firmicutes 49.67% (2.72) 51.58% (3.03) 0.97 
Bacteroidetes 35.18% (2.11) 38.34% (2.45) 0.09 
Bifidobacterium 0.50% (0.19) 0.68% (0.27) 0.24 
Lactobacillus 0.16% (0.13) 0.47% (0.45) 0.18 
-Diversity 1.83% (0.07) 1.78% (0.09) 0.81 
aLeast squares mean (standard error of the mean) 
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Figure 9.  Abundance of Firmicutes and Bacteroidetes at week 3 and week 5. 
 
There was a non-significant increase in Firmicutes and Bacteroidetes between week 3 
and week 5.  
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Figure 10. Abundance of Bifidobacterium and Lactobacillus at week 3 and week 5. 
There was a non-significant increase in Bifidobacterium and Lactobacillus between week 
3 and week 5.
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Figure 11. Alpha diversity at week 3 and week 5. 
There was a non-significant decrease in -diversity between week 3 and week 5.  
4.5 Statistical methods 
Statistical analysis was performed on a personal computer with JMP software (SAS 
Institute Inc., Cary, NC). Analysis of variance was used to evaluate variance in both body 
weight and BMI between baseline and the two health checks. Paired t-test was used to 
evaluate any variance in calories, macronutrients, vitamins, and minerals consumed by 
the participants between week 3 and week 5. Paired t-test was used to evaluate -
diversity and relative abundance of the different bacterial groups between week 3 and 
week 5. In all statistical tests performed, P values of ≤0.05 were considered significant. 
Analysis of anthropometrics, 3-day diet records, and bacterial abundance and diversity 
were performed on 10 participants. 
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5. DISCUSSION 
The present study assessed the effect of strawberries (13 g FDSP/d) on gut health in a 5-
week diet intervention trial with one treatment group. Strawberry consumption was not 
associated with significant changes in measures of adiposity (i.e. body weight, BMI) or 
changes in diet (i.e. macronutrients, vitamins, minerals) except for sugar, vitamin B12, 
and fruit consumption. There were no significant differences in -diversity or any 
bacteria phyla or genera. The data suggests that strawberry consumption at 13 g/d FDSP 
does not result in significant changes to obesity-associated gut microbiota or beneficial 
bacteria genera.  
The current research is unique compared to previous research for several reasons. The 
population was composed of postmenopausal women, a population that is strikingly 
underrepresented in nutrition research. Postmenopausal women were selected as the 
study population as they are a target for gut dysbiosis and exhibit increased CVD risk. As 
previously discussed, studies show that polyphenol rich fruits like strawberries may 
ameliorate dysbiosis and decrease CVD risk. In addition, to our knowledge, three 
studies131-133 have investigated diet and gut health in postmenopausal women, while no 
study has assessed the effect of strawberries and gut health in postmenopausal women. 
One strawberry diet intervention study analyzed the combined effect of strawberry 
puree, raspberries, and cloudberries on gut health,19 however, the population was not 
comprised of postmenopausal women and the intervention material was not strictly 
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strawberries. Furthermore, this is the first study to evaluate the effect of strawberries 
on gut health in postmenopausal women.  
5.1 Measures of Adiposity 
Participants did not exhibit significant differences in any measure of adiposity from 
baseline to week 5, nor were any significant differences seen between population 
groups. While no previous research has evaluated the effect of strawberry consumption 
on body weight or BMI in postmenopausal women, these findings are consistent with 
other gut health diet interventions. In a 6-wk RCT evaluating probiotic strains and fiber 
on gut composition in overweight postmenopausal women, there were no significant 
differences in anthropometric measures compared with placebo.132 Similarly, in a red 
wine polyphenol gut health study, researchers did not observe a significant difference in 
weight from baseline to end of intervention.9 Likewise, a 4-wk RCT assessing cocoa-
derived flavanols on gut health found no significant change in BMI.127 Weight loss or 
gain was not anticipated for the current research and the data reflects this.   
5.2 3-Day Diet Records 
This study was supplementary in nature and therefore did not include a controlled diet 
regimen; however, in the course of 5-weeks, participants did not show any significant 
differences in macronutrients, vitamins, or minerals except for sugar (g), vitamin B12 
(μg), and fruit consumption. Fruit consumption increased, but upon further analysis, the 
1 serv/d fruit from the FDSP accounted for the significant increase in fruit consumption. 
Therefore, it may be the case that any changes in the gut microbiota, while statistically 
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insignificant, were a response to strawberry supplementation. Likewise, the relatively 
high sugar content of 13 g FDSP explained the significant increase in sugar intake 
between week 3 and week 5. This reveals that strawberry intake significantly 
contributed to overall sugar consumption.  
5.3 Gut Microbiota  
Following strawberry supplementation, participants did not show a significant change in 
bacteria abundance (i.e. Firmicutes, Bacteroidetes, Bifidobacterium, Lactobacillus) or -
diversity. Our hypothesis was that we would see a decrease in Firmicutes and/or an 
increase in Bacteroidetes (leading to a decrease in F:B ratio), an increase in 
Bifidobacterium and Lactobacillus, and that there would be an increase in -diversity 
following diet intervention. However, at the end of the study, there was no statistically 
significant change in any of these three objectives.   
Previous research of similar study design and duration also did not detect significant 
changes in the relative abundance of gut microbiota as demonstrated by raspberry 
puree supplementation18 and supplementation consisting of a mixture of berries 
(including strawberries).19 Conversely, a range of high polyphenol fruits in both mice and 
human models appear to have the ability to significantly alter the gut microbiota 
composition in ways that may benefit the host.9,11,16,134 Notably, strawberry powder 
supplementation (~167 g fresh strawberry) for 37 days increased -diversity and 
alleviated dysbiosis by increasing probiotic bacteria (e.g. Bifidobacterium and 
Lactobacillus) in mice with colitis. Additionally, strawberry powder (~160 g fresh 
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strawberry) administered for 10 weeks was shown to increase Bifidobacterium in 
diabetic mice. However, 2-weeks of strawberry consumption at the current dose (~125 g 
fresh strawberry) did not alter the microbiota in postmenopausal women in a 
statistically significant way.   
The finding that there was no significant change in bacteria and diversity could be due 
to sample size, supplement dosing, study duration, and interindividual variability in 
bacteria composition. The study’s small sample size resulted in less accurate mean 
values, and therefore less power to detect change. The lack of change possibly indicates 
that the supplement dose was not high enough to detect significant change or that the 
study duration was not sufficiently long. It is possible that a higher dose of strawberry or 
a longer duration may encourage growth of different strains of bacteria that may have 
been reflected in significant values and an increased alpha diversity. Research indicates 
that freeze dried blueberries at a dose of 25 g (375 mg anthocyanins) for six weeks 
results in significant changes in the gut composition.16 Considering that blueberries have 
a much higher polyphenol concentration than strawberries, a dose of strawberries at 
least this amount (while adjusting for density) should be implemented in future studies. 
Additionally, the variability in gut composition between participants renders it difficult 
to measure the true efficacy of the intervention. While the increase in Bifidobacterium 
and Lactobacillus was insignificant, participants eliminated polyphenol foods from their 
diet, so in theory, the slight increase in these beneficial bacterial could have resulted 
from the strawberry. These preliminary findings, while valuable to shape future research 
methods, cannot be generalized to the current target population.  
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While no significant shifts in the F:B ratio were measured, it is important to note that we 
were not able to measure total bacteria count. It is known that bacteria such as 
Firmicutes and Bacteroidetes ferment plant-based substances and thus it is likely that 
introducing FDSP into the diet increased the total bacteria load. Bacterial load can vary 
greatly in response to factors such as diet and health84; a recent study published in 
Nature found that healthy individuals compared to unhealthy individuals have one order 
of magnitude higher bacteria load.135 This indicates that given a longer length of an 
increased polyphenol diet, a significant effect on the gut microbiota may have occurred–
at some point, there may have been enough growth of total bacteria populations to 
change the ratio significantly. 
With this consideration, the association between a higher F:B ratio and obesity may be a 
spurious conclusion, since it does not disclose information about total bacteria 
populations or changes in these populations. The ratio only reveals that the relative 
population growth or decline causes one phylum of bacteria to grow or decline to shift 
the ratio, but there is no way to know, for example, the rate at which Firmicutes is 
changing compared to Bacteroidetes. It could be that both phyla increased but one just 
increased faster than the other, resulting in a shift in the ratio.  
Theory says that obese individuals have a high baseline F:B ratio,48 but considering the 
current data, since all we could test for is ratio, an alternative consideration may be that 
the unhealthy gut conditions associated with obesity simply lowers overall populations 
of bacteria. It may also be that diets that generally lead to obesity may be less favorable 
to large populations of gut bacteria as opposed to plant-based diets that encourage 
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fermentation and therefore larger populations of bacteria. Total bacteria population 
numbers may be a better indicator of gut health than ratio,135 which may explain why 
discrepancies regarding the F:B ratio exist in the literature. Recent literature supports 
the observation that there is currently no taxonomic signature of obesity that exists in 
the gut microbiome.53  
Furthermore, the F:B ratio has been shown to both negatively and positively correlate 
with BMI,53,136 so perhaps limiting the study population by this measure is premature. It 
may be beneficial to determine at what dose strawberry polyphenols affect the gut 
microbiota in postmenopausal women before restricting the population by weight.  
5.4 Conclusion 
In the context of gut health, studies have emphasized the importance of analyzing 
whole diets versus evaluating changes in microbial populations from isolated 
compounds. Foods contain different mixtures of fiber and polyphenols, and results from 
studies analyzing single compounds could reach different conclusions from conclusions 
drawn from the context of real life.137 As such, the strawberries may work synergistically 
via its numerous health promoting compounds to confer health to the host through the 
gut. For this reason, this study analyzed how whole strawberry consumption in a diet 
may favorable alter the gut microbiota. 
In addition, while there is a wealth of literature supporting the association between 
ratios of bacteria phyla and obesity, the pathogenesis of obesity is multifactorial and is 
likely more complicated than a simple shift in Firmicutes and Bacteroidetes. Much of the 
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supporting evidence linking the F:B ratio to obesity was from murine studies which 
complicates the extrapolation of mouse research to humans. It could be more beneficial 
to first look at the absolute quantity of microbes and evaluate how these numbers 
correlate with disease and subsequently see how different species and their metabolites 
influence health. 
5.5 Strengths and Limitations 
This study was short in duration to minimize attrition and maximize participation. 
Another strength is that the free-living nature of the study closely mimics reality which 
allows the results to be better generalized to other populations. Additionally, 
participants were given individually labeled, pre-packaged, single serving strawberry 
powder for each day of the week. This enabled participants to easily keep track of their 
intake, therefore ensuring they consumed the proper quantity of strawberry each day. 
Another strength is that the portion size and type of strawberries (fresh and frozen 
cultivars available throughout the US) as well as the concentration and type of 
polyphenols was likely consistent within each individual and between subjects since 
participants were consuming homogenized powder from the same batch. Further, 
uBiome was utilized for all stool sample processing making it possible to expand the 
study to Fresno county. Samples were shipped directly to the lab, as opposed to 
processing at Cal Poly, giving the study a high degree of flexibility. Outsourcing sample 
analysis also decreased chances of sample contamination by human error and 
minimized human exposure to potentially harmful pathogens. Lastly, a washout period 
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was utilized to standardize the detection of the effect of the strawberry powder by 
reducing inter-subject variation. 
This study is limited by the relatively small sample size – a larger sample size may have 
yielded more power to detect significant results. However, pilot studies do not have a 
defined sample size. Additionally, no control group was used so we cannot conclude for 
certain the true effect of the treatment. A cross-over RCT would be the preferred study 
design for a diet intervention of this type. Additionally, a more restricted diet as 
opposed to free-living may have better standardized detection of changes by reducing 
intersubject variability. Finally, the sample of feces collected was very small and may not 
have been representative of the overall proportion of feces to bacteria that inhabit the 
intestine.  
5.6 Future Research  
As this is a pilot study, it was designed as a preliminary study for a larger 18-week study 
being conducted by future graduate students in the department of Food Science and 
Nutrition at Cal Poly-SLO. The 18-week study will look at the effect of strawberries on 
gut health in addition to their impact on heart health. The methodology tested in this 
research will have established a more seamless process to recruit and screen 
participants, was effective in troubleshooting any equipment problems, and familiarized 
the study team with procedures. Furthermore, a pilot study enabled the main study to 
run more smoothly by solving many of the minor problems encountered during the pilot 
phase.  
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In addition, the data generated gave a first impression of the variability of the data and 
established feasibility given the population. This study provided the opportunity to 
evaluate the representativeness of the sample in addition to the relative cost and time 
necessary to conduct it. Even with the small sample size, the data can still be used to 
draw basic conclusions to help inform the 18-week study. Since we used resources to 
minimize labor and cost, the 18-week study with better reflect any potential effect the 
strawberries may have on heart and gut health. 
  
 72 
REFERENCES 
 
1. Conlon MA, Bird AR. The Impact of Diet and Lifestyle on Gut Microbiota and 
 Human Health. In: Nutrients. Vol 7.2015:17-44. 
 
2. Chan YK, Estaki M, Gibson DL. Clinical consequences of diet-induced dysbiosis. 
 Ann Nutr Metab. 2013;63 Suppl 2:28-40. 
 
3. Musso G, Gambino R, Cassader M. Obesity, Diabetes, and Gut Microbiota: The 
 hygiene hypothesis expanded? In: Diabetes Care. Vol 33.2010:2277-2284. 
 
4. Horstman AM, Dillon EL, Urban RJ, Sheffield-Moore M. The Role of Androgens 
 and Estrogens on Healthy Aging and Longevity. J Gerontol A Biol Sci Med 
 Sci. 2012;67(11):1140-1152. 
 
5. Rossi R, Grimaldi T, Origliani G, Fantini G, Coppi F, Modena MG. Menopause and 
 cardiovascular risk. Pathophysiol Haemost Thromb. 2002;32(5-6):325-
 328. 
 
6. Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen-gut microbiome axis: 
 Physiological and clinical implications. Maturitas. 2017;103:45-53. 
 
7. Santos-Marcos JA, Rangel-Zuniga OA, Jimenez-Lucena R, et al. Influence of 
 gender and menopausal status on gut microbiota. Maturitas.  
 2018;116:43-53. 
 
8. Laparra JM, Sanz Y. Interactions of gut microbiota with functional food  
 components and nutraceuticals. Pharmacol Res. 2010;61(3):219-225. 
 
9. Queipo-Ortuno MI, Boto-Ordonez M, Murri M, et al. Influence of red wine 
 polyphenols and ethanol on the gut microbiota ecology and biochemical 
 biomarkers. Am J Clin Nutr. 2012;95(6):1323-1334. 
 
10. Moreno-Indias I, Sanchez-Alcoholado L, Perez-Martinez P, et al. Red wine  
 polyphenols modulate fecal microbiota and reduce markers of the  
 metabolic syndrome in obese patients. Food Funct. 2016;7(4):1775-1787. 
 
11. Molan AL, Liu Z, Plimmer G. Evaluation of the effect of blackcurrant products on 
 gut microbiota and on markers of risk for colon cancer in humans.  
 Phytother Res. 2014;28(3):416-422. 
 
 73 
12. Li Z, Henning SM, Lee RP, et al. Pomegranate extract induces ellagitannin  
 metabolite formation and changes stool microbiota in healthy volunteers.
 Food Funct. 2015;6(8):2487-2495. 
 
13. Shinohara K, Ohashi Y, Kawasumi K, Terada A, Fujisawa T. Effect of apple intake 
 on fecal microbiota and metabolites in humans. Anaerobe.   
 2010;16(5):510-515. 
 
14. Duque AL, Monteiro M, Adorno MA, Sakamoto IK, Sivieri K. An exploratory study 
 on the influence of orange juice on gut microbiota using a dynamic 
 colonic model. Food Research International. 2016;84:160-169. 
 
15. Mitsou EK, Kougia E, Nomikos T, Yannakoulia M, Mountzouris KC, Kyriacou A. 
 Effect of banana consumption on faecal microbiota: a randomised, 
 controlled trial. Anaerobe. 2011;17(6):384-387. 
 
16. Vendrame S, Guglielmetti S, Riso P, Arioli S, Klimis-Zacas D, Porrini M. Six-week 
 consumption of a wild blueberry powder drink increases bifidobacteria in 
 the human gut. J Agric Food Chem. 2011;59(24):12815-12820. 
 
17. Ige BA. Effect of blueberry on the bacteria flora of the gut with special reference 
 to Lactobacillus. African Journal of Microbiology    
 Research 2013;7(26):3416-3420  
 
18. Gill CI, McDougall GJ, Glidewell S, et al. Profiling of phenols in human fecal water 
 after raspberry supplementation. J Agric Food Chem. 2010;58(19):10389-
 10395. 
 
19. Puupponen-Pimia R, Seppanen-Laakso T, Kankainen M, et al. Effects of  
 ellagitannin-rich berries on blood lipids, gut microbiota, and urolithin 
 production in human subjects with symptoms of metabolic syndrome. 
 Mol Nutr Food Res. 2013;57(12):2258-2263. 
 
20. Berdanier CD. The Human Microbiota. Nutrition Today. 2018;53(3):125–131. 
 
21. Rastelli M, Knauf C, Cani PD. Gut Microbes and Health: A Focus on the  
 Mechanisms Linking Microbes, Obesity, and Related Disorders. Obesity. 
 2018;26(5):792-800. 
 
22. Lynch SV, Pedersen O. The Human Intestinal Microbiome in Health and Disease. 
 N Engl J Med. 2016;375(24):2369-2379. 
 
23. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. 
 Physiol Rev. 2010;90(3):859-904. 
 74 
24. Rinninella E, Raoul P, Cintoni M, et al. What is the Healthy Gut Microbiota  
 Composition? A Changing Ecosystem across Age, Environment, Diet, and 
 Diseases. In: Microorganisms. Vol 7.2019. 
 
25. Barengolts E. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN 
 MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED 
 CONTROLLED TRIALS. Endocr Pract. 2016;22(10):1224-1234. 
 
26. Wexler AG, Goodman AL. An insider's perspective: Bacteroides as a window into 
 the microbiome. Nat Microbiol. 2017;2:17026. 
 
27. Reichardt N, Duncan SH, Young P, et al. Phylogenetic distribution of three  
 pathways for propionate production within the human gut microbiota. In: 
 ISME J. Vol 8.2014:1323-1335. 
 
28. Rajilic-Stojanovic M, de Vos WM. The first 1000 cultured species of the human 
 gastrointestinal microbiota. FEMS Microbiol Rev. 2014;38(5):996-1047. 
 
29. Rivière A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and Butyrate-
 Producing Colon Bacteria: Importance and Strategies for Their  
 Stimulation in the Human Gut. Front Microbiol. 2016;7:979. 
 
30. Gérard P. Metabolism of Cholesterol and Bile Acids by the Gut Microbiota. 
 Pathogens. 2014;3(1):14-24. 
 
31. Kamada N, Chen GY, Inohara N, Núñez G. Control of Pathogens and Pathobionts 
 by the Gut Microbiota. Nat Immunol. 2013;14(7):685-690. 
 
32. Nicholson JK, Holmes E, Kinross J, et al. Host-gut microbiota metabolic  
 interactions. Science. 2012;336(6086):1262-1267. 
 
33. Hylemon PB, Harris SC, Ridlon JM. Metabolism of hydrogen gases and bile acids 
 in the gut microbiome. FEBS Lett. 2018;592(12):2070-2082. 
 
34. Joyce SA, MacSharry J, Casey PG, et al. Regulation of host weight gain and lipid 
 metabolism by bacterial bile acid modification in the gut. Proc Natl Acad 
 Sci U S A. 2014;111(20):7421-7426. 
 
35. Rowland I, Gibson G, Heinken A, et al. Gut microbiota functions: metabolism of 
 nutrients and other food components. In: Eur J Nutr. Vol 57.2018:1-24. 
 
36. Listing of vitamins. Harvard Health Publishing.     
 https://www.health.harvard.edu/staying-healthy/listing_of_vitamins. 
 Published August 14, 2017. Accessed March 14, 2019. 
 75 
37. Tuohy KM, Fava F, Viola R. 'The way to a man's heart is through his gut  
 microbiota'--dietary pro- and prebiotics for the management of  
 cardiovascular risk. Proc Nutr Soc. 2014;73(2):172-185. 
 
38. Chambers ES, Viardot A, Psichas A, et al. Effects of targeted delivery of  
 propionate to the human colon on appetite regulation, body weight 
 maintenance and adiposity in overweight adults. Gut. 2015;64(11):1744-
 1754. 
 
39. Hansen TH, Gobel RJ, Hansen T, Pedersen O. The gut microbiome in cardio-
 metabolic health. Genome Med. 2015;7(1):33. 
 
40. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal 
 angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci 
 U S A. 2002;99(24):15451-15455. 
 
41. Wong JM. Gut microbiota and cardiometabolic outcomes: influence of dietary 
 patterns and their associated components. Am J Clin Nutr. 2014;100 
 Suppl 1:369s-377s. 
 
42. Structure, function and diversity of the healthy human microbiome. Nature. 
 2012;486(7402):207-214. 
 
43. M K. What are alpha, beta, and gamma diversity? | Socratic. @SocraticOrg. 
 https://socratic.org/questions/what-are-alpha-beta-and-gamma-
 diversity. Published 2019. Accessed April 2019. 
 
44. Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition 
 and health. Bmj. 2018;361:k2179. 
 
45. Modi SR, Collins JJ, Relman DA. Antibiotics and the gut microbiota. In: J Clin 
 Invest. Vol 124.2014:4212-4218. 
 
46. Sonnenburg JL, Backhed F. Diet-microbiota interactions as moderators of human 
 metabolism. Nature. 2016;535(7610):56-64. 
 
47. Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbiota in human adults 
 with type 2 diabetes differs from non-diabetic adults. PLoS One.  
 2010;5(2):e9085. 
 
48. Ley RE, Turnbauch PJ, Klein S, Gordon JI. Human gut microbes associated with 
 obesity Nature. 2006;444:1022-1023. 
 
 76 
49. Mariat D, Firmesse O, Levenez F, et al. The Firmicutes/Bacteroidetes ratio of the 
 human microbiota changes with age. BMC Microbiol. 2009;9:123. 
 
50. Murphy EF, Cotter PD, Healy S, et al. Composition and energy harvesting capacity 
 of the gut microbiota: relationship to diet, obesity and time in mouse 
 models. Gut. 2010;59(12):1635-1642. 
 
51. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity 
 alters gut microbial ecology. Proc Natl Acad Sci U S A.   
 2005;102(31):11070-11075. 
 
52. Schwiertz A, Taras D, Schafer K, et al. Microbiota and SCFA in lean and  
 overweight healthy subjects. Obesity (Silver Spring). 2010;18(1):190-195. 
 
53. Finucane MM, Sharpton TJ, Laurent TJ, Pollard KS. A taxonomic signature of 
 obesity in the microbiome? Getting to the guts of the matter. PLoS One. 
 2014;9(1):e84689. 
 
54. Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-
 carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 
 2013;19(5):576-585. 
 
55. Velasquez MT, Ramezani A, Manal A, Raj DS. Trimethylamine N-Oxide: The Good, 
 the Bad and the Unknown. In: Toxins (Basel). Vol 8.2016. 
 
56. Murri M, Leiva I, Gomez-Zumaquero JM, et al. Gut microbiota in children with 
 type 1 diabetes differs from that in healthy children: a case-control study. 
 BMC Med. 2013;11:46. 
 
57. Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol. 
 2014;11(8):497-505. 
 
58. Crouzet L, Gaultier E, Del'Homme C, et al. The hypersensitivity to colonic  
  distension of IBS patients can be transferred to rats through their fecal 
 microbiota. Neurogastroenterol Motil. 2013;25(4):e272-282. 
 
59. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An 
 obesity-associated gut microbiome with increased capacity for energy 
 harvest. Nature. 2006;444(7122):1027-1031. 
 
60. Jumpertz R, Le DS, Turnbaugh PJ, et al. Energy-balance studies reveal  
 associations between gut microbes, caloric load, and nutrient absorption 
 in humans. Am J Clin Nutr. 2011;94(1):58-65. 
 77 
61. Geurts L, Neyrinck AM, Delzenne NM, Knauf C, Cani PD. Gut microbiota controls 
 adipose tissue expansion, gut barrier and glucose metabolism: novel 
 insights into molecular targets and interventions using prebiotics. Benef 
 Microbes. 2014;5(1):3-17. 
 
62. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and 
 insulin resistance. Diabetes. 2007;56(7):1761-1772. 
 
63. Gummesson A, Carlsson LM, Storlien LH, et al. Intestinal permeability is  
 associated with visceral adiposity in healthy women. Obesity (Silver 
 Spring). 2011;19(11):2280-2282. 
 
64. Radilla-Vazquez RB, Parra-Rojas I, Martinez-Hernandez NE, Marquez-Sandoval 
 YF, Illades-Aguiar B, Castro-Alarcon N. Gut Microbiota and Metabolic 
 Endotoxemia in Young Obese Mexican Subjects. Obes Facts. 2016;9(1):1-
 11. 
 
65. Goodrich JK, Waters JL, Poole AC, et al. Human genetics shape the gut  
 microbiome. Cell. 2014;159(4):789-799. 
 
66. Zwielehner J, Liszt K, Handschur M, Lassl C, Lapin A, Haslberger AG. Combined 
 PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal 
 population sizes and diversity of Bacteroides, bifidobacteria and  
 Clostridium cluster IV in institutionalized elderly. Exp Gerontol.  
 2009;44(6-7):440-446. 
 
67. Claesson MJ, Cusack S, O'Sullivan O, et al. Composition, variability, and temporal 
 stability of the intestinal microbiota of the elderly. In: Proc Natl Acad Sci 
 U S A. Vol 108.2011:4586-4591. 
 
68. Ottman N, Smidt H, de Vos WM, Belzer C. The function of our microbiota: who is 
 out there and what do they do? Front Cell Infect Microbiol. 2012;2:104. 
 
69. Teixeira TF, Grzeskowiak L, Franceschini SC, Bressan J, Ferreira CL, Peluzio MC. 
 Higher level of faecal SCFA in women correlates with metabolic syndrome 
 risk factors. Br J Nutr. 2013;109(5):914-919. 
 
70. Hu GX, Chen GR, Xu H, Ge RS, Lin J. Activation of the AMP activated protein 
 kinase by short-chain fatty acids is the main mechanism underlying the 
 beneficial effect of a high fiber diet on the metabolic syndrome. Med 
 Hypotheses. 2010;74(1):123-126. 
 
 78 
71. Tarini J, Wolever TM. The fermentable fibre inulin increases postprandial serum 
 short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy 
 subjects. Appl Physiol Nutr Metab. 2010;35(1):9-16. 
 
72. Brahe LK, Le Chatelier E, Prifti E, et al. Specific gut microbiota features and 
 metabolic markers in postmenopausal women with obesity. Nutr  
 Diabetes. 2015;5:e159. 
 
73. Lobo RA. Metabolic syndrome after menopause and the role of hormones. 
 Maturitas. 2008;60(1):10-18. 
 
74. Davis SR, Castelo-Branco C, Chedraui P, et al. Understanding weight gain at 
 menopause. Climacteric. 2012;15(5):419-429. 
 
75. Dahlman-Wright K, Cavailles V, Fuqua SA, et al. International Union of  
 Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev. 2006;58(4):773- 
 781. 
 
76. Chen KL, Madak-Erdogan Z. Estrogen and Microbiota Crosstalk: Should We Pay 
 Attention? Trends Endocrinol Metab. 2016;27(11):752-755. 
 
77. Capurso G, Lahner E. The interaction between smoking, alcohol and the gut 
 microbiome. Best Pract Res Clin Gastroenterol. 2017;31(5):579-588. 
 
78. Luo B, Xiang D, Nieman DC, Chen P. The effects of moderate exercise on chronic 
 stress-induced intestinal barrier dysfunction and antimicrobial defense. 
 Brain Behav Immun. 2014;39:99-106. 
 
79. Mika A, Van Treuren W, Gonzalez A, Herrera JJ, Knight R, Fleshner M. Exercise is 
 More Effective at Altering Gut Microbial Composition and Producing 
 Stable Changes in Lean Mass in Juvenile versus Adult Male F344 Rats. 
 PLoS One. 2015;10(5):e0125889. 
 
80. O'Sullivan O, Cronin O, Clarke SF, et al. Exercise and the microbiota. Gut  
 Microbes. 2015;6(2):131-136. 
 
81. David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the 
 human gut microbiome. Nature. 2014;505(7484):559-563. 
 
82. Ley RE, Hamady M, Lozupone C, et al. Evolution of mammals and their gut 
 microbes. Science. 2008;320(5883):1647-1651. 
 
 79 
83. Anhe FF, Varin TV, Le Barz M, et al. Gut Microbiota Dysbiosis in Obesity-Linked 
 Metabolic Diseases and Prebiotic Potential of Polyphenol-Rich Extracts. 
 Curr Obes Rep. 2015;4(4):389-400. 
 
84. Fava F, Gitau R, Griffin BA, Gibson GR, Tuohy KM, Lovegrove JA. The type and 
 quantity of dietary fat and carbohydrate alter faecal microbiome and 
 short-chain fatty acid excretion in a metabolic syndrome 'at-risk'  
 population. Int J Obes (Lond). 2013;37(2):216-223. 
 
85. Singh RK, Chang HW, Yan D, et al. Influence of diet on the gut microbiome and 
 implications for human health. J Transl Med. 2017;15(1):73. 
 
86. Caesar R, Tremaroli V, Kovatcheva-Datchary P, Cani P, Bäckhed F. Crosstalk 
 between Gut Microbiota and Dietary Lipids Aggravates WAT  
 Inflammation through TLR Signaling. In: Cell Metab. Vol 22.2015:658-668. 
 
87. De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut  
 microbiota revealed by a comparative study in children from Europe and 
 rural Africa. Proc Natl Acad Sci U S A. 2010;107(33):14691-14696. 
 
88. Swiatecka D, Narbad A, Ridgway KP, Kostyra H. The study on the impact of 
 glycated pea proteins on human intestinal bacteria. Int J Food Microbiol. 
 2011;145(1):267-272. 
 
89. Costabile A, Klinder A, Fava F, et al. Whole-grain wheat breakfast cereal has a 
 prebiotic effect on the human gut microbiota: a double-blind, placebo-
 controlled, crossover study. Br J Nutr. 2008;99(1):110-120. 
 
90. Etxeberria U, Arias N, Boque N, et al. Reshaping faecal gut microbiota  
 composition by the intake of trans-resveratrol and quercetin in high-fat 
 sucrose diet-fed rats. J Nutr Biochem. 2015;26(6):651-660. 
 
91. Ravussin Y, Koren O, Spor A, et al. Responses of gut microbiota to diet  
 composition and weight loss in lean and obese mice. Obesity (Silver 
 Spring). 2012;20(4):738-747. 
 
92. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, et al. High-fat diet determines the 
 composition of the murine gut microbiome independently of obesity. 
 Gastroenterology. 2009;137(5):1716-1724.e1711-1712. 
 
93. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese 
 and lean twins. Nature. 2009;457(7228):480-484. 
 80 
94. Duncan SH, Lobley GE, Holtrop G, et al. Human colonic microbiota associated 
 with diet, obesity and weight loss. Int J Obes (Lond). 2008;32(11):1720-
 1724. 
 
95. Yoshimoto S, Loo TM, Atarashi K, et al. Obesity-induced gut microbial metabolite 
 promotes liver cancer through senescence secretome. Nature.  
 2013;499(7456):97-101. 
 
96. Islam KB, Fukiya S, Hagio M, et al. Bile acid is a host factor that regulates the 
 composition of the cecal microbiota in rats. Gastroenterology.  
 2011;141(5):1773-1781. 
 
97. Devkota S, Wang Y, Musch MW, et al. Dietary-fat-induced taurocholic acid 
 promotes pathobiont expansion and colitis in. Nature.   
 2012;487(7405):104. 
 
98. Lee YK. Effects of Diet on Gut Microbiota Profile and the Implications for Health 
 and Disease. In: Biosci Microbiota Food Health. Vol 32.2013:1-12. 
 
99. Zimmer J, Lange B, Frick JS, et al. A vegan or vegetarian diet substantially alters 
 the human colonic faecal microbiota. Eur J Clin Nutr. 2012;66(1):53-60. 
 
100. 2015–2020 Dietary Guidelines for Americans. U.S. Department of Health and 
 Human Services and U.S. Department of     
 Agriculture https://health.gov/dietaryguidelines/2015/guidelines/. 
 Published December 2015. Accessed April, 2019. 
 
101. De Filippis F, Pellegrini N, Vannini L, et al. High-level adherence to a  
 Mediterranean diet beneficially impacts the gut microbiota and  
 associated metabolome. Gut. 2016;65(11):1812-1821. 
 
102. Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in 
 intestinal health and disease. Nat Rev Gastroenterol Hepatol.  
 2010;7(9):503-514. 
 
103. Rajkumar H, Mahmood N, Kumar M, Varikuti SR, Challa HR, Myakala SP. Effect of 
 probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity,  
 inflammatory markers, and gut colonization in overweight adults: a 
 randomized, controlled trial. Mediators Inflamm. 2014;2014:348959. 
 
104. Yang YJ, Chuang CC, Yang HB, Lu CC, Sheu BS. Lactobacillus acidophilus  
 ameliorates H. pylori-induced gastric inflammation by inactivating the  
Smad7 and NFκB pathways. In: BMC Microbiol. Vol 12.2012:38. 
 81 
105. Zillman C. In the business of fruit, who's really top banana? Fortune.  
 http://fortune.com/2014/11/04/best-selling-fruit-us/. Published 2014. 
 Accessed 2019. 
 
106. Plattner K, Perez A. U.S. strawberry consumption continues to grow.  
 https://www.ers.usda.gov/data-products/chart-gallery/gallery/chart-
 detail/?chartId=77884. Published 2014. Accessed 2019. 
 
107. Espin JC, Gonzalez-Sarrias A, Tomas-Barberan FA. The gut microbiota: A key 
 factor in the therapeutic effects of (poly)phenols. Biochem Pharmacol. 
 2017;139:82-93. 
 
108. Tomas-Barberan FA, Selma MV, Espin JC. Interactions of gut microbiota with 
 dietary polyphenols and consequences to human health. Curr Opin Clin 
 Nutr Metab Care. 2016;19(6):471-476. 
 
109. Afrin S, Gasparrini M, Forbes-Hernandez TY, et al. Promising Health Benefits of 
 the Strawberry: A Focus on Clinical Studies. J Agric Food Chem.  
 2016;64(22):4435-4449. 
 
110. Grubinger V. History of the Strawberry. UVM EXTENSION'S VERMONT  
 VEGETABLE AND BERRY PROGRAM.  Published 2012. Accessed 2019. 
 
111. Giampieri F, Tulipani S, Alvarez-Suarez JM, Quiles JL, Mezzetti B, Battino M. The 
 strawberry: composition, nutritional quality, and impact on human 
 health. Nutrition. 2012;28(1):9-19. 
 
112. Higdon J. Fiber. Linus Pauling Institute.  Published 2012. Accessed April 11, 2019. 
 
113. Higdon J. Vitamin C. Linus Pauling Institute.      
 https://lpi.oregonstate.edu/mic/vitamins/vitamin-C. Published 2018. 
 Accessed April 16, 2019. 
 
114. Burton-Freeman B, Linares A, Hyson D, Kappagoda T. Strawberry modulates LDL 
 oxidation and postprandial lipemia in response to high-fat meal in  
 overweight hyperlipidemic men and women. J Am Coll Nutr.  
 2010;29(1):46-54. 
 
115. Basu A, Fu DX, Wilkinson M, et al. Strawberries decrease atherosclerotic markers 
 in subjects with metabolic syndrome. Nutr Res. 2010;30(7):462-469. 
 
116. Zunino SJ, Parelman MA, Freytag TL, et al. Effects of dietary strawberry powder 
 on blood lipids and inflammatory markers in obese human subjects. Br J 
 Nutr. 2012;108(5):900-909. 
 82 
117. Liu CJ, Lin JY. Anti-inflammatory and anti-apoptotic effects of strawberry and 
 mulberry fruit polysaccharides on lipopolysaccharide-stimulated  
 macrophages through modulating pro-/anti-inflammatory cytokines 
 secretion and Bcl-2/Bak protein ratio. Food Chem Toxicol.   
 2012;50(9):3032-3039. 
 
118. Gasparrini M, Forbes-Hernandez TY, Giampieri F, et al. Protective Effect of 
 Strawberry Extract against Inflammatory Stress Induced in Human Dermal 
 Fibroblasts. Molecules. 2017;22(1). 
 
119. Hervert-HernÃ¡ndez D, Hervert-HernÃ¡ndez D. Dietary Polyphenols and Human 
 Gut Microbiota: a Review. Food reviews international. 2011-02-
 28;27(2):154-169. 
 
120. Roopchand DE, Carmody RN, Kuhn P, et al. Dietary Polyphenols Promote Growth 
 of the Gut Bacterium Akkermansia muciniphila and Attenuate High-Fat 
 Diet-Induced Metabolic Syndrome. Diabetes. 2015;64(8):2847-2858. 
 
121. Wankhade UD, Zhong Y, Lazarenko OP, et al. Sex-Specific Changes in Gut  
 Microbiome Composition following Blueberry Consumption in C57BL/6J 
 Mice. In: Nutrients. Vol 11.2019. 
 
122. Molyneux RJ, Lee ST, Gardner DR, Panter KE, James LF. Phytochemicals: the 
 good, the bad and the ugly? Phytochemistry. 2007;68(22-24):2973-2985. 
 
123. Giampieri F, Alvarez-Suarez JM, Battino M. Strawberry and human health: effects 
 beyond antioxidant activity. J Agric Food Chem. 2014;62(18):3867-3876. 
 
124. Kim JM, Kim KM, Park EH, et al. Anthocyanins from black soybean inhibit  
 Helicobacter pylori-induced inflammation in human gastric epithelial AGS 
 cells. Microbiol Immunol. 2013;57(5):366-373. 
 
125. Alvarez-Suarez JM, Giampieri F, Tulipani S, et al. One-month strawberry-rich 
 anthocyanin supplementation ameliorates cardiovascular risk, oxidative 
 stress markers and platelet activation in humans. J Nutr Biochem.  
 2014;25(3):289-294. 
 
126. Suzuki T, Hara H. Quercetin enhances intestinal barrier function through the 
 assembly of zonula [corrected] occludens-2, occludin, and claudin-1 and 
 the expression of claudin-4 in Caco-2 cells. J Nutr. 2009;139(5):965-974. 
 
127. Tzounis X, Rodriguez-Mateos A, Vulevic J, Gibson GR, Kwik-Uribe C, Spencer JP. 
 Prebiotic evaluation of cocoa-derived flavanols in healthy humans by 
 83 
 using a randomized, controlled, double-blind, crossover intervention 
 study. Am J Clin Nutr. 2011;93(1):62-72. 
 
128. Larrosa M, Luceri C, Vivoli E, et al. Polyphenol metabolites from colonic  
 microbiota exert anti-inflammatory activity on different inflammation 
 models. Mol Nutr Food Res. 2009;53(8):1044-1054. 
 
129. Tomas-Barberan FA, Garcia-Villalba R, Gonzalez-Sarrias A, Selma MV, Espin JC. 
 Ellagic acid metabolism by human gut microbiota: consistent observation 
 of three urolithin phenotypes in intervention trials, independent of food 
 source, age, and health status. J Agric Food Chem. 2014;62(28):6535- 
 6538. 
 
130. Almonacid DE, Kraal L, Ossandon FJ, et al. 16S rRNA gene sequencing and healthy 
 reference ranges for 28 clinically relevant microbial taxa from the human 
 gut microbiome. PLoS One. 2017;12(5):e0176555. 
 
131. Christensen EG, Licht TR, Kristensen M, Bahl MI. Bifidogenic effect of whole-grain 
 wheat during a 12-week energy-restricted dietary intervention in  
 postmenopausal women. Eur J Clin Nutr. 2013;67(12):1316-1321. 
 
132. Brahe LK, Le Chatelier E, Prifti E, et al. Dietary modulation of the gut microbiota a 
 randomised controlled trial in obese postmenopausal women. Br J Nutr. 
 2015;114(3):406-417. 
 
133. Aleman JO, Bokulich NA, Swann JR, et al. Fecal microbiota and bile acid  
 interactions with systemic and adipose tissue metabolism in diet-induced 
 weight loss of obese postmenopausal women. J Transl Med.  
 2018;16(1):244. 
 
134. Han Y, Song M, Gu M, et al. Dietary Intake of Whole Strawberry Inhibited Colonic 
 Inflammation in Dextran-Sulfate-Sodium-Treated Mice via Restoring 
 Immune Homeostasis and Alleviating Gut Microbiota Dysbiosis. J Agric 
 Food Chem. 2019. 
 
135. Vandeputte D, Kathagen G, D’hoe K, et al. Quantitative microbiome profiling 
 links gut community variation to microbial load. Nature.   
 2017;551(7681):507. 
 
136. Koliada A, Syzenko G, Moseiko V, et al. Association between body mass index 
  and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. In: 
 BMC Microbiol. Vol 17.2017. 
 84 
137. Cuervo A, Valdes L, Salazar N, et al. Pilot study of diet and microbiota: interactive 
 associations of fibers and polyphenols with human intestinal bacteria. J 
 Agric Food Chem. 2014;62(23):5330-5336. 
 
138. Basu A, Wilkinson M, Penugonda K, Simmons B, Betts NM, Lyons TJ. Freeze-dried 
 strawberry powder improves lipid profile and lipid peroxidation in  
 women with metabolic syndrome: baseline and post intervention effects. 
 Nutr J. 2009;8:43. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 85 
APPENDICES 
 
A. Nutrient composition of freeze-dried strawberry powder* 
 
Nutrient   Per 100 g 
Proximates     
Water (g)   10.3 
Ash (g)   4.31 
Calories (kcal)   350 
Calories from Fat (kcal)   15.2 
Protein (g)   6.83 
Total lipid (g)   1.7 
Carbohydrate (g)   76.9 
Dietary Fiber (g)   14.3 
Sugars, total (g)   61.2 
Fructose (g)   28.8 
Glucose (g)   24.4 
Sucrose (g)   8.1 
Minerals     
Calcium (ppm)   1730 
Iron (ppm)   32.1 
Potassium (ppm)   16800 
Sodium (ppm)   102 
Vitamins     
Vitamin C (mg)   346 
Thiamin (mg)   0.06 
Riboflavin (mg)   0.048 
Niacin (mg)   0.4 
Pantothenic acid (mg)   0.115 
Vitamin B6 (mg)   0.0207 
Folate (mg)   0.0399 
* Source: California Strawberry Commission      
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B. Polyphenol composition of freeze-dried strawberry powder. Estimated 
values* 
 
  Per 13 g 
Total phenolics (mg)1 521.58 
Total anthocyanins (mg)2 40.04 
Ellagic acid (mg) 10.66 
*Adapted from Basu, 2009138  
1expressed as mg gallic acid equivalents  
2expressed as mg cyanidin-3-glucoside 
equivalents   
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C. List of food sources high in probiotics and polyphenols 
  
 
 
 
 
 
Strawberries	and	Gut	Health	in	Post-menopausal	Women	
Dietary	Intake	Directions	for	Washout		
&	Supplement	Intervention	Periods	
While	participating	in	this	study,	please	maintain	your	current	diet	pattern,	but	avoid	dietary	sources	
that	are	high	in	polyphenols	and	probiotics.	In	addition,	do	not	consume	greater	than	5	servings	a	week	
of	soy,	green	tea,	or	cocoa	products.	In	addition	to	avoiding	the	foods	listed	below,	please	adhere	to	the	
following	directions	during	your	participation	in	this	study:	
● Do	not	smoke	or	consume	tobacco		
● One	alcoholic	beverage	is	equal	to	12	oz	beer,	5	oz	wine,	and	1.5	oz	distilled	spirit		
● Do	not	follow	an	energy	restricted	or	low-fat	diet	(<20%	energy	from	fat)	
Probiotic	Foods		
	
Polyphenol	Sources		
(other	than	what	is	provided	during	diet	
intervention)		
AVOID	 Alternatives	 	 AVOID	 Alternatives	
Yogurt	(limit	to	½	cup	or	4	
ounces	per	day)		
Yogurts	that	do	not	
contain	'Live	&	Active	
Cultures'	seal	 	
Alcohol	-	wine	&	beer	
(limit	to	<5	servings	per	
week)	
Apple	juice,	Pineapple	
Juice,	Grape	Juice			
Kefir		 Avoid	
	
Green	Tea,	Black	Tea,	
Oolong	Tea		 Chamomile	tea	
Kombucha	tea		 Avoid	
	
Cocoa	Powder	and	
associated	products:		high-
cocoa,	polyphenol-rich	
chocolate	(i.e.	semi-sweet	
chocolate;	dark	chocolate=	
>60%	chocolate)	
White	Chocolate	
Tempeh	 Avoid	
	
Berries:	(strawberries,	
blueberries,	blackberries,	
cranberries,	raspberries,	
etc.)	(limit	to	≤	1	cup/wk)	
	
Melons	(cantaloupe,	
honeydew,	watermelon),	
Kiwi	(green),	Mango,	
Pineapple,	Apples,	Figs,	
Canned	Peaches			
	
Cultured	Condiments	
(horseradish,	pickle	relish,	
sauerkraut)	
Avoid	
	
Plums	 Persimmons	
Natto	 Avoid	
	
Grapes	(red	&	black)	
Grapes	(green),	Dried	
Cranberries,	Raisins	
Probiotic	and	Prebiotic	
Supplements	
Avoid	 	 Pomegranates	(≤1/wk)	 Bananas	
	 	 	 Cherries	 Fruit	jellies	&	jams	
	   
Nuts	(pecans,	hazelnut,	
walnut)	*OK	to	consume	if	
already	part	of	daily	diet	
Almonds,	Cashews,	
Macadamia	nuts,	
Peanuts,	Pistachios	
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D. Example template of 3-Day Food Record 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strawberries and Gut Health in Postmenopausal Women 
3-Day Diet Record 
   
Study ID: _______________ 
Date: __________________ 
 
At the end of each washout and diet intervention period, use this worksheet to record (in detail) all foods and beverages you 
consume throughout the day.  
Instructions to Remember:  
1. Start a new page for each day of recording. Note: the exact days that you record your diet intake should correspond to the 
exact days you record your physical activity on the 3-Day Physical Activity record forms. 
2. Maintain your current eating patterns. Any foods recorded on this form should represent your usual intake. 
3. List any vitamin, mineral, or other supplements taken on the back side of this worksheet.  
*Do not forget to include water and alcohol in this record. 
*Examples are shown in the shaded rows. 
Time Meal/Snack 
Food or Beverage Item 
(Name and Description) 
Brand/Source 
(manufacturer, if 
available) 
Preparation 
Method 
(bake, boil, fry, 
etc.) 
Amount/Wt 
(ounces, grams, fluid 
ounces, cups, tsp, Tbsp) 
8:15 
am 
 Total Cereal General Mills NA 1 oz/1 cup 
8:15 
am 
 Light Soy milk, vanilla Silk NA 4 fl oz/.5 cup 
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E. Example template of 3-Day Physical Activity Record 
 
 
 
 
 
 Strawberries and Gut Health in Postmenopausal Women 
3-Day Physical Activity Record 
 
Study ID: _______________ 
Date: __________________ 
Use this worksheet to record any physical activity you engage in during the last week of the washout and/or diet intervention study 
phases (depending on which study phase you are in). 
Instructions: 
1. Maintain your current level of physical activity. Any activity recorded on this form should represent your usual level/intensity 
of exercise. 
2. Start a new page for each day of recording.  
3. Activity record should correspond to the exact days of the 3-Day Diet Record. 
4. Please refer to the definitions of low, moderate, and high intensity (shown below) when completing your records. 
*  
Low Activity 
requires minimal to no effort with no 
change in heart rate 
Moderate Activity 
requires a moderate amount of effort and 
causes increased breathing with a 
moderate increase in heart rate 
High Activity 
requires a large amount of effort and 
causes rapid breathing and a substantial 
increase in heart rate 
− walking slowly 
− sitting at computer 
− standing light work (cooking, 
washing dishes) 
− stretching 
− fishing 
− playing catch 
− light yard/house work 
− walking briskly 
− heavy cleaning (washing windows, 
vacuuming, mopping) 
− mowing lawn  
− bicycling lightly  
− hiking  
− recreational swimming 
− jogging/running 
− mountain climbing 
− bicycling more than 10mph 
− step aerobics 
− jump roping 
− treading water 
 
 
 
 
 
 
 
 
 
 
 
 
 Strawberries and Gut Health in Postmenopausal Women 
3-Day Physical Activity Record 
 
Study ID: _______________ 
Date: __________________ 
Examples are shown in the shaded rows.  
Time of Day 
Physical Activity 
performed 
Description of Activity 
Intensity (*low, mod., 
high) 
Duration 
8:00am Jogging 
Jogged around 
neighborhood 
Moderate 15 minutes 
  
 
   
  
 
   
  
 
   
  
 
   
  
 
   
  
 
   
  
 
   
  
 
   
 
 
 
    
 
